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Introduction
Presence of carotid artery stenosis is generally known as one of the risk factors for
ischemic stroke. Approximately 20% of all ischemic strokes are considered to be
caused by atherosclerosis of the carotid bifurcation. Other possible causes are cardio-
embolic events or local atherosclerosis in the smaller arteries nearby the site of an
infarct. For almost 60 years, patients with atherosclerotic lesions in the carotid
bifurcation have been treated surgically by carotid endarterectomy.1 The selection
of those patients that benefit the most from this procedure, however, has remained
unclear for a long period of time. In the last decade two large randomised trials, the
North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the
European Carotid Surgery Trial (ECST) have proven that endarterectomy reduces the
risk of recurrent ipsilateral stroke in symptomatic patients with a severe stenosis
(70-99%) of the internal carotid artery (ICA).2,3 Subgroups of patients with a 50-69%
stenosis may also expect a benefit from carotid endarterectomy, however, this benefit
is only marginally significant. Furthermore, it has been shown that an increasing
degree of stenosis yielded increasing benefit from surgery. Therefore, a precise
estimate of the degree of stenosis in the ICA is crucial in selecting the patients that
benefit from carotid endarterectomy.
In the trials mentioned above the degree of stenosis was assessed with digital
subtraction angiography (DSA), which consequently has become the standard of
reference in the diagnosis of carotid artery stenosis. This invasive procedure, however,
has a small but significant risk of morbidity and mortality, which decreases the
potential overall benefit of endarterectomy.4 Even patients without apparent
neurological complications after DSA have been shown to develop minor
asymptomatic infarctions due to micro-embolisms.5 Medical technology, however,
is rapidly developing and new diagnostic imaging techniques have become available.
To date, non-invasive tests such as duplex ultrasound (DUS) and magnetic resonance
angiography (MRA) are increasingly used in the diagnosis of carotid artery stenosis.
These tests do not carry the potential risk of complications. However, with regard to
the results of the carotid surgery trials, it remains very important that the correct
group of patients is selected by new test strategies.
Over the last decade, many diagnostic studies have been published in which DUS,
MRA, or combinations of these tests were compared with DSA.6-8 In Chapter 2 of
this thesis a systematic review of the literature on diagnostic studies from 1994 to
2001 is described. Recently, in line with our findings, a review of previous publications
on this topic published between 1993 and 1998 criticised the design of the studies.9
Often, the  study populations were small, or the diagnostic test results were collected
retrospectively. Furthermore, from the limited published evidence available to date,
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the cost-effectiveness of carotid endarterectomy and of the preoperative investigations
remains unclear.10 Apparently still insufficient evidence is available to take considered
policy decisions on the replacement of DSA by non-invasive testing. The need for a
prospective diagnostic study including a cost-effectiveness analysis has repeatedly
been recognised in the literature.11
The objective of this thesis was to determine if DSA could be replaced by
non-invasive testing. First, it was important to obtain a valid thorough evaluation of
non-invasive imaging techniques and to provide reliable estimates of the diagnostic
accuracy of DUS, MRA, and a combination of these tests compared to DSA as
reference standard. From January 1997 to November 2000 nearly 400 consecutive
patients suspected of having carotid artery stenosis, in whom carotid endarterectomy
was considered, were included in a prospective diagnostic study. All patients
underwent DUS, MRA, and DSA examination. The complete content of this study and
the estimates of the accuracy of the non-invasive tests are presented in Chapter 3.
The limitations of a diagnostic study are discussed and the best non-invasive strategy
is presented based on the diagnostic performance. However, to be able to understand
the consequences of implementation of non-invasive imaging strategies from a
societal perspective, a valid estimate of the diagnostic accurasy is not sufficient.
Additionally, a cost-effectiveness analysis was performed, which is presented in
Chapter 4. The long-term implications, expected quality of life, and total lifetime
costs could be studied by means of a diagnostic and prognostic decision model.
In the Chapters 5 and 6 further test specific characteristics of MRA are described.
In Chapter 5 the overestimation of the degree of stenosis by MRA compared with
DSA is analysed and a possible explanation is proposed. In Chapter 6, the occurrence
of flow related artefacts, one of the drawbacks of MRA, is investigated and its
meaning in clinical practice is discussed. A recent development in MRA imaging is
contrast-enhanced MRA (CE-MRA). This technique utilises a small amount of
intravenous contrast. CE-MRA was studied in a sub-population of 50 consecutive
patients and the diagnostic value is described in Chapter 7. Finally, in Chapter 8,
the patients’ preferences for DUS, MRA, and DSA, and possible discomforts related
to the particular tests are presented. In Chapter 9 the results of the different studies
are recapitulated and discussed.
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Figure 1. Example of a digital subtraction angiography (DSA) showing a severe stenosis (arrow)
in the internal carotid artery (ICA). The common carotid artery (CCA) and the external carotid
artery (ECA) in this image show a normal lumen.
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DUS and MRA compared to DSA, a systematic review
Abstract
Purpose:
To review and compare the published data on the diagnostic value of Duplex
ultrasonography (DUS), Magnetic resonance angiography (MRA) and conventional
Digital subtraction angiography (DSA) for the diagnosis of carotid artery stenosis.
Data sources:
Systematic review of published studies retrieved through PUBMED, bibliographies
of review papers, and experts.
Study selection:
The English-language medical literature was searched for studies that met the
following selection criteria: 1) publications published between 1994 and 2001;
2) time-of-flight MRA or contrast-enhanced MRA and/or DUS were performed to
estimate the severity of carotid artery stenosis; 3) DSA was used as the standard of
reference; 4) the absolute numbers of true-positives, false-negatives, true-negatives,
and false-positives were available or derivable for at least one definition of disease
(degree of stenosis).
Data extraction:
Two authors (Y.vd.G and P.J.N) independently extracted predefined clinical and
diagnostic parameters from eligible studies.
Results:
Sixty-three publications on duplex, MRA, or both were included in the analysis,
yielding the test results of 64 different patient series on DUS and 21 on MRA.
For the diagnosis of a 70-99% vs <70% stenosis, MRA had a pooled sensitivity of
95%(CI, 92% to 97%) and a pooled specificity of 90% (CI, 86% to 93%). These
numbers were 86% (CI, 84% to 89%) and 87% (CI, 84% to 90%) for DUS, respectively.
For recognizing occlusion MRA yielded a sensitivity of 98% (CI, 94% to 100%) and
a specificity of 100% (CI, 99% to 100%) and DUS had a sensitivity of 96% (CI, 94%
to 98%) and a specificity of 100% (CI, 99% to 100%). A multivariable summary
ROC analysis for diagnosing 70-99% stenosis demonstrated that the type of MR
scanner predicted the performance of MRA, whereas the presence of verification
bias predicted the performance of DUS. For diagnosing occlusion no significant
20
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heterogeneity was found for MRA; for DUS the presence of verification bias and
type of DUS scanner were explanatory variables. In the comparative multivariable
summary ROC model with adjustment for the explanatory covariates, MRA had a
significantly better discriminatory power than DUS in diagnosing 70-99% stenosis
(regression coefficient 1.6 (CI, 0.37 to 2.77)). No significant difference was found in
detecting occlusion (0.73 (CI, -2.06 to 3.51)).
Conclusions:
The results suggest that MRA has a better discriminatory power compared with DUS
in diagnosing 70-99% stenosis and is a sensitive and specific test compared to DSA
in the evaluation of carotid artery stenosis. For detecting occlusion both DUS and
MRA are very accurate.
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Introduction
Two large randomized clinical trials, The North American Symptomatic Carotid
Endarterectomy Trial (NASCET) and the European Carotid Surgery Trial (ECST), have
proven the benefit of carotid endarterectomy in patients with severe symptomatic
carotid artery stenosis, 70-99%.1,2 Recent publications have shown that subgroups of
patients with a 50-69% stenosis may also expect a small benefit from carotid
endarterectomy.3 The diagnosis of severe stenosis (70-99%), however, remains crucial
for the majority of patients. The degree of stenosis in the endarterectomy trials was
established by DSA, which has become the standard of reference for selecting patients
for carotid surgery. DSA, however, has a relatively high risk of morbidity and mortality
ranging from 1% to 4% in patients with atherosclerosis.4 Even patients without
apparent neurological complications after DSA have been shown to develop minor
asymptomatic infarctions due to micro-embolisms.5
Magnetic resonance angiography (MRA) and contrast-enhanced magnetic resonance
angiography (CE-MRA) are increasingly used supplementary to duplex
ultrasonography (DUS) and conventional digital subtraction angiography (DSA) in
the diagnosis of carotid artery stenosis.6 Many institutions have published diagnostic
studies in which MRA and/or DUS were compared with DSA. The results suggest
that the decision to perform carotid endarterectomy could be based one or a
combination of these non-invasive tests. Two meta-analytic reviews have been
published summarizing literature on the diagnostic performance of DUS and MRA
from before 1996, one reporting an increasing role for non-invasive testing in carotid
artery disease (DUS and MRA),7 the other concluding moderate test results for MRA.8
Recently a review of previous publications on this topic published between 1993
and 1998 criticized the design of the studies and proposed guidelines for diagnostic
studies.9
The purpose of this study was to systematically review the contemporary literature
and to compare the diagnostic performance of DUS, MRA, and CE-MRA. Our aim
was to increase precision by combining published studies and to determine variables
that might explain part of the difference in outcome across the studies. Recently
published guidelines for meta-analyses of randomized controlled trials were followed
where they were applicable to a meta-analysis on diagnostic tests.10
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M e t h o d s
Study selection
We performed a literature search for publications on the diagnostic performance of either
DUS, MRA, or a combination of these two modalities in patients with carotid artery stenosis
in which DSA was used as the standard of reference. We chose to limit our search to the
period from January 1994 to December 2001. Since 1994 there has been a rise in publications
on MRA. We decided not to go further back in time because technical possibilities and
imaging protocols of these non-invasive tests have developed considerably over time, making
comparison between new and old studies less meaningful.
To find the studies we performed a PUBMED search using the following keywords and all
possible related terms: carotid artery, angiography, combined with magnetic resonance and/
or duplex or ultrasound. We limited the search to publications published in the English
language. Reference lists of original and review publications on this subject were checked
and experts on the subject were consulted to find additional studies.
Studies were included that met the following criteria: 1) published between 1994 and 2001;
2) MRA or CE-MRA and/or DUS were performed to estimate the severity of carotid artery
stenosis; 3) DSA was used as the reference standard; 4) the absolute numbers of true-positive,
false-negatives, true-negatives, and false-positives were available or derivable from the
presented data for at least one cutoff criterion for the degree of stenosis based on DSA.  We
reconstructed these numbers if sensitivity, specificity, and the prevalence of the disease were
presented.
Our intention was to collect the absolute numbers for each study as completely as
possible for the following categories of carotid artery stenosis: 0-29%, 30-49%,
50-69%, 70-99%, 100%. Authors were contacted for two reasons: 1) to give them
the opportunity to send us additional data so that we could work with a complete
dataset for all described categories; 2) if neither absolute numbers or sensitivity/
specificity were derivable but the study suggested availability of this data. Studies
with occlusion as their main outcome (often describing diagnostic tests only to
determine if occlusion was present or not) were excluded if the author did not
respond to our request for more precise specification of the non-occlusion group.
We excluded these studies because the main subject of our meta-analysis was
treatment decisions based on the category of 70-99% stenosis and because the
cutoff criterions used in these publications were too diverse to include in the
meta-analysis. We also excluded studies with a population of less than 15 patients.
If publications used the same or an overlapping population we chose the publication
from which we could derive the required data in the most straightforward manner.
We contacted the authors if it was not clear whether separate published populations
were overlapping.
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Data extraction
Two authors (YvdG) and (PN) independently extracted data from all publications.
All abstracts collected from PUBMED on the basis of the described search criteria
were evaluated. The full text was studied to check the inclusion criteria from all
studies that could not definitely be excluded on the basis of the abstract. From the
included publications the absolute numbers of true-positives, false-negatives,
true-negatives, and false-positives of the described test modalities were extracted
as completely as possible for all the different categories of stenosis: 0-29%, 30-49%,
50-69%, 70-99%, 100%. Sensitivity and specificity were extracted or calculated
from the data and absolute numbers were derived if the prevalence was reported.
Additionally the following variables were extracted for each study population: mean
age and range, percentage of men and women, percentage of symptomatic patients,
type of symptoms (amourosis fugax, transient ischemic attack, or stroke), and if the
tests were studied in a consecutive patient population. The following test
characteristics were determined: used method of stenosis measurement on DSA
(according to NASCET or ECST criteria or a different method), type of MR and/or
DUS machine, time interval between DUS and/or MRA and DSA, the number of
visualized carotid arteries and whether a different cutoff was used to define severe
stenosis (eg. 60% or 80% instead of 70% stensosis). We converted cutoff values
determined according to ECST criteria to their corresponding NASCET criteria.
In studies presenting DUS results, often more than one velocity parameter (peak
systolic velocity, end diastolic velocity, mean velocity) or a ratio was used to
determine the degree of stenosis. We chose the parameter that the authors considered
as optimal. Single PSV-values referring to a degree of stenosis of 70% were extracted
if available. We determined whether the DUS thresholds were defined before the
study was performed or if the optimal thresholds had been analyzed afterwards on
the basis of the results (yielding a higher diagnostic performance). We also noted if
verification bias was present, which may exist if the decision to perform the reference
standard procedure depends on the results of the test under investigation.11 (In practice
DUS is often used as the screening test to select patients for DSA). In the MRA
studies use of a protocol with an intaveneous contrast agent was noted. Finally, we
determined whether tests were read with the observer blinded for the results of the
other test(s). Discrepancies between the two observers in the extracted data were
discussed and in all cases resolved through consensus.
Analyses
The analyses presented are limited to two groups: 70-99% (severe stenosis) vs <70%
and 100% (occlusion) vs < 100%. The data collected from the other subgroups under
the 70% threshold (0-29%, 30-49%, 50-69%) were not included in the presented
24
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analyses. The data in these groups contained too many missing values for a meaningful
analysis, even though some publications presented a very complete description of
the data and some of the authors gave enthusiastic replies to our request for additional
data. Furthermore, we thought that the data of the 30-49% and 50-69% stenosis
categories might suffer from selection and/or verification bias because many
institutions use a threshold nearby 50% stenosis on DUS as their inclusion criterion
to perform DSA. For both reasons the analyses in these stenosis groups gave very
inconsistent preliminary results.
All variables that were analyzed are listed in Table 1. Gender and distribution of
disease (i.e. localization of the event) were often missing which precluded meaningful
analysis.
Pooled weighted analysis
We calculated the pooled weighted results of sensitivity, specificity, and the
diagnostic performance. The diagnostic performance was defined as the natural
logarithm of the diagnostic odds ratio D=ln[(TPxTN)/(FPxFN)]. Weighting was done
with the inverse of the variance. We used a random effects model to account for the
heterogeneity across studies.
1. Test specific positivity criterion (S)
2. Publication year
3. Proportion symptomatic (assuming all symptomatic if not mentioned)
4. Consecutive patients included in the cohort
5. Verification bias
6. Blinded interpretation of test results
7. Measuring of stenosis by NASCET-method
8. Choice of a different cutoff to define severe stenosis
9. Type of DUS machine used
10. Gadolinium (contrast agent) used for MRA
11. Type of MR machine used
12. Time between non-invasive test and angiography
13. Peak systolic velocity (PSV) cutoff value for 70% stenosis on DUS
14. PSV positivity criterion determined after the study
15. Age
Table 1: Variables extracted from publications and analysed in the described models for each
study population.
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Summary ROC Analysis
To adjust for the heterogeneity in positivity criteria a summary ROC analysis was performed
for each test.12 Summary ROC analysis is a meta-analytic method to summarize true- and false
positive rates from different diagnostic studies.13 In this method the postivity criterion of each
study is approximated by calculating S=ln[(TPxFP)/(TNxFN)].
Initially we applied both a fixed and a random effects model in all analyses. The fixed effects
model assumes that the operating points from the individual studies lie on one
underlying true ROC-curve, and that the differences in test results can be explained
by differences in positivity criteria and other definable covariates. The random
effects summary ROC model assumes there is always some residual cross-study
heterogeneity even after adjustment for differences in positivity criteria and
characteristics such as population-size, age, gender, definition of disease, scanner-
type, blinded-scoring, and verification bias.14 In the remaining sections of this paper
we will only present the methods and results of the random effects summary ROC
model. In the discussion we will elaborate on the differences in outcome between
the random and the fixed effects model.
Summary ROC analysis by diagnostic test
Summary ROC models were developed for each diagnostic test separately. In a
bivariable analysis we evaluated each covariate (Table 1) to determine its
explanatory value in explaining differences across studies in diagnostic performance
(D) after adjustment for the used positivity criterion (S).Variables were considered
explanatory in the random effects analysis if their inclusion decreased the estimate
of the between-study-variance by at least 10% (which was calculated with the
method-of-moments), if they had a regression coefficient of at least 1.0 for dummy
variables or 1.0 over the range of the variable, or if they were statistically signifi-
cant (p<0.05).15 Subsequently, multivariable summary ROC models were developed
for each diagnostic test separately. The explanatory variables from the bivariable
analysis were evaluated in a stepwise forward selection regression model including
variables one-by-one, starting with the variable that increased the adjusted R-squared
the most, and keeping the variable in the model using the same selection criteria as
above. S (indicating the positivity criterion) was retained in the model irrespective
of its significance.
Summary ROC analysis comparing MRA and DUS
Finally, we performed a summary ROC analysis for the comparison between Duplex
and MRA. The significant variables from the multivariable analysis performed for
each test separately were included as test-specific covariates in the multivariable
comparative model. A dummy variable was added to compare the two tests.
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The regression coefficient of this dummy variable represents the difference in
diagnostic performance (D) of MRA compared to DUS. A positive regression
coefficient indicates better discriminatory power of MRA compared to DUS and a
negative coefficient indicates reduced discriminatory ability of MRA.
Results
Overview of studies
The PUBMED search yielded a little over 900 references. After evaluating the
abstracts we retrieved 151 publications for further study. Sixty-two papers met our
inclusion criteria completely.16-77 The included 62 publications yielded 85 separate
study populations: 21 series on MRA and 64 series on DUS (Figure 1). Nine publications
reported on both MRA and DUS results.16,23,36,62,65,70,72-74 Five publications presented
more than one study population and/or multi-center studies containing data varying
from 2 to 10 institutions.23,24,46,58,60 Forty-six authors were contacted in an attempt to
obtain additional data. Three of these authors were contacted because different
publications suggested the availability of data about (part of) the same
study-population. The over-all response rate was 30%. Thirteen authors replied and
sent us their more complete data. Two authors did answer but wrote that they could
not retrieve the necessary numbers. Twenty of the remaining 31 publications were
nevertheless included on the basis of the reported results only. Although several
reports are now available on Gadolinium-enhanced MRA, test-results validated with
DSA as the reference standard in a population larger than 15 patients were published
in only 4 series.20,23,39,41
900 abstracts from PUBMED
151 articles studied
62 articles included
64 series on DUS & 21 series on MRA
Figure 1: Flow diagram of inclusion of the patient series.
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Pooled weighted analysis
For the diagnosis of a 70-99% vs <70% stenosis, MRA had a pooled sensitivity of
95% (CI, 92% to 97%) and a pooled specificity of 90% (CI, 86% to 93%) (Table 2).
These numbers were 86% (CI, 84% to 89%) and 87% (CI, 84% to 90%) for DUS,
respectively. For diagnosing occlusion (<100% vs 100%) MRA had a sensitivity of
98% (CI, 94% to 100%) and a specificity of 100% (CI, 99% to 100%), and for DUS
these numbers were 96% (CI, 94% to 98%) and 100% (CI, 99% to 100%).
These pooled data indicate a better discriminatory power for MRA in diagnosing
severe stenosis (70-99%) whereas MRA and DUS are equally good in recognizing
carotid occlusion (100%). The pooled values of D (the natural logarithm of the
diagnostic odds ratio) were very similar between tests: 4.1 (CI, 3.5 to 4.8) for MRA
vs 4.0 (CI, 3.5 to 4.5) for DUS in the 70-99% category and 6.5 (CI, 5.7 to 7.4) for
MRA vs 6.5 (CI, 5.9 to 7.0) for DUS in diagnosing occlusion.
Pooled sensitivity (%) (95% CI) Pooled specificity (%) (95% CI)
MRA DUS MRA DUS
70-99% vs
<70%
95 (92 to 97) 86 (84 to 89) 90 (86 to 93) 87 (84 to 90)
<100% vs 100% 98 (94 to 100) 96 (94 to 98) 100 (99 to 100) 100 (99 to 100)
Table 2: Pooled weighted sensitivity and specificity calculated in a random effects model.
Summary ROC analysis by diagnostic test
In the multivariable model for the diagnosis of 70-99% stenosis type of MR scanner
was a significant predictor for the diagnostic performance of MRA, whereas presence
of verification bias and choice of a different cutoff to define severe stenosis were
associated with a better performance of DUS. In recognizing occlusion no
significant heterogeneity was demonstrated among the MRA studies. Presence of
verification bias and type of DUS scanner were significant predictors for DUS.
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Summary ROC analysis comparing MRA and DUS
The multivariable comparative model with adjustment for significant predictors
demonstrated a regression coefficient for MRA vs DUS of 1.6 (CI, 0.37 to 2.77,
p=0.01)  for 70-99% vs <70% stenosis. In differentiating occlusion from <100%
stenosis the regression coefficient for MRA vs DUS was 0.73 (CI, -2.06 to 3.51,
p=0.51). These numbers mean that for the distinction of <70% vs 70-99% stenosis
MRA discriminates significantly better than DUS, whereas for the distinction
between occlusion and <100% no difference in diagnostic performance could be
demonstrated. The multivariable summary ROC curves were constructed using the
final comparative model, and are presented in figures 1 and 2 for both MRA and
DUS for the diagnosis of severe stenosis (70-99%). The summary ROC curve for
DUS was adjusted to reflect a cutoff of 70% for severe stenosis and the absence of
verification bias. The summary ROC curve for MRA was adjusted to reflect the most
commonly used types of MR scanners. The dots represent the original true positive
and true negative rates of the individual publications.
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Figure2. Multivariable summary ROC model
(line) for diagnosing severe stenosis on DUS,
and original data from individual studies (dots).
The summary ROC curve is adjusted to reflect
a cutoff of 70% for severe stenosis and the
absence of verification bias.
Figure 3. Multivariable summary ROC
model (line) for diagnosing 70-99% vs <70%
stenosis on MRA, and original data from
individual studies (dots). The summary ROC
curve is adjusted to reflect the most commonly
used types of MR scanners.
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Discussion
In this paper we systematically reviewed and compared the diagnostic value of
DUS and MRA with DSA for the diagnosis of carotid artery stenosis. Our results
suggest that for the distinction of <70% vs 70-99% stenosis MRA has a significantly
better discriminatory power than DUS, whereas for the distinction between occlusion
vs no occlusion there is no significant difference in diagnostic performance.
According to our random effects model the difference between DUS results across
studies for diagnosing a 70-99% stenosis can be explained (in part) by the presence
of verification bias and choice of a different cutoff to define severe stenosis.
For MRA the type of MR scanner was an explanatory variable. For diagnosing 100%
vs <100% with DUS, presence of verification bias and type of DUS scanner were
explanatory variables; for MRA no heterogeneity was found among the different
studies.
An earlier meta-analysis published by Blakeley ea. in 1995 concluded that DUS
and MRA had similar diagnostic performance in predicting carotid artery occlusion
and >70% stenosis.7 In our study we found a better discriminatory power for MRA
compared with their results. In the study by Blakeley ea. the literature from 1977 to
1993 was reviewed, whereas our literature search started as of 1994. Improved MRA
technology might explain an increase in diagnostic performance of MRA. Kallmes
ea. reviewed MRA studies published between 1990 and 1994, and also found a
lower sensitivity for MRA in recognising severe carotid artery stenosis than we did.8
Furthermore, they discussed whether the asymptomatic arteries should be excluded
from the results. Exclusion of the asymptomatic side in their analyses gave even
lower sensitivities.
A limitation in the collection of our data was the fact that, to be able to perform a
summary ROC analysis, we could include only those studies from which absolute
numbers (TP,FP,TN and FN) for at least one defined threshold were available or
derivable. Often only sensitivities and specificities were presented. When we were
unable to reconstruct the absolute numbers, or when authors did not reply to our
request for additional data, we needed to exclude the paper. Therefore, it was only
possible to include a selection of the contemporary literature in this analysis.
Furthermore, in the included papers we often found incomplete or missing data
concerning population baseline characteristics, distribution of disease, and technical
aspects of the imaging protocols. For some of the variables these missings precluded
meaningful analysis.
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In the meta-analysis we first calculated the pooled sensitivities and specificities.
This method provides a relatively crude estimate of the overall diagnostic performance
of the different tests. The pooled weighted analysis showed that both DUS and MRA
are highly sensitive and specific for diagnosing carotid artery occlusion. For the
diagnosis of occlusion only the absence of  signal needs to be determined, while
judgement of the severity of a stenosis is not necessary. For detecting the 70%
cutoff MRA showed a better sensitivity and slightly better specificity than DUS.
MRA probably gives a more precise estimate of the degree of stenosis because it
provides a direct measurement of the stenotic lumen (NASCET-method), whereas
DUS only allows an indirect estimate through measurement of parameters based on
blood flow velocities. Therefore, DUS gives a wider dispersion in results when
compared with DSA, resulting in lower sensitivities and specificities. The pooled
sensitivity and specificity of 95% and 90% respectively for MRA in detecting severe
stenosis are very high. This technique will probably improve even further in the
near future, for example by the increased use of contrast-enhanced protocols.
To date, however, only a few studies have been published reporting the results of
contrast-enhanced MRA validated against DSA precluding a meaningful analysis in
this study.
Apart from calculating pooled weighted sensitivities and specificities we also
performed a summary ROC analysis, which is especially useful to evaluate overall
diagnostic performance. The main advantage of this method is the fact that it adjusts
for different positivity criteria, which cannot be achieved with pooling sensitivities
and specificities. Initially we studied both a fixed and a random effects model in
the summary ROC analyses. Although the random-effects model seems more
elegant in a meta-analysis combining the results from diverse studies, in a diagnostic
meta-analysis a fixed effects model in our opinion can also be justified.
Study-populations selected for a specific test and disease often have comparable
baseline characteristics which supports the assumption of a true underlying ROC
curve. Because of the stricter assumptions, the fixed effects model can potentially
identify additional explanatory variables. In our study the fixed and random effects
model showed good consistency in finding significant variables that explain
(part of) the heterogeneity of the different publications. For DUS publication year
was found as an additional explanatory variable for the diagnosis of severe stenosis
(70-99%) when the fixed effects model was applied. Earlier studies showed better
diagnostic performance, indicating a possible effect of publication bias. Alternatively,
this finding may indicate the selection bias that commonly occurs in early studies
of new diagnostic technologies. In the diagnosis of occlusion a consecutive study
population was found as additional significant variable for MRA.
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Remarkably the type of MR scanner but not the type of DUS scanner was shown to
be an explanatory variable in the diagnosis of a 70-99% stenosis. It is generally
known that different DUS machines with different technologists in different institutions
show variable test results, even if the same thresholds for the test parameters are
used.78 For MRA scanners this difference has not been shown previously. The type of
MR scanner probably represents not only the brand of the machine but also used
software and imaging protocols. This would mean that, like for DUS, in clinical
practice each institution should probably validate its own machine and imaging
protocol.
The fact that verification bias plays an important role in detecting 70-99% stensoses
on DUS is a plausible and important finding. Verification bias may exist if the
decision to perform the reference standard procedure depends on the results of the
test under investigation. In the included studies DUS has often been used as a
screening test to decide whether to perform DSA.
In conclusion, our results suggest that MRA has a better discriminatory power
compared with DUS in recognising 70-99% stenosis, and is a sensitive and specific
test compared to DSA in the evaluation of carotid artery stenosis.  For detecting
occlusion of the carotid artery both modalities are very accurate. To determine if
non-invasive tests can replace DSA in clinical practice, however, not only the test
results, but also a cost-effectiveness analysis based on the diagnostic accuracies
should be taken into account.
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Abstract
Background and Purpose:
Carotid endarterectomy has been shown to be beneficial in symptomatic patients
with a severe stenosis (70-99%) of the internal carotid artery (ICA). Digital subtraction
angiography (DSA) is the standard of reference in the diagnosis of carotid artery
stenosis, but has a relatively high complication rate. In a diagnostic study we
investigated whether DSA could be replaced by non-invasive testing.
Methods:
In a prospective diagnostic study we performed duplex ultrasound (DUS), magnetic
resonance angiography (MRA), and DSA on 350 consecutive symptomatic patients.
Stenoses were measured with the observers blinded for clinical information and
other test results. Separate and combined test results of DUS and MRA were compared
with the reference standard DSA. Only the stenosis measurements of the arteries on
the symptomatic side were included in the analyses.
Results:
DUS analysed with previously defined criteria resulted in a sensitivity of 87.5%
(95%CI, 82.1%-92.9%) and a specificity of 75.7% (95%CI, 69.3%-82.2%) in
identifying severe ICA stenosis (70-99%). Stenosis measurements on MRA yielded a
sensitivity of 92.2% (95%CI, 86.2%-96.2%) and a specificity of 75.7% (95%CI, 68.6%-
82.5%). Combining MRA and DUS results, agreement between these two modalities
(84% of patients) gave a sensitivity of 96.3% (95%CI, 90.8%-99.0%) and a specificity
of 80.2% (95%CI, 73.1%-87.3%) for identifying severe stenosis.
Conclusion:
DUS and MRA seem accurate diagnostic tests to detect carotid artery stenosis.
In a non-invasive diagnostic strategy, however, both tests should subsequently be
performed. If DUS and MRA are in agreement, the combined test result yield a high
sensitivity and specificity, making DSA redundant for the decision on carotid
endarterectomy. In the event of disagreement, however, DSA should still be
considered.
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Introduction
Carotid endarterectomy was shown to be beneficial in symptomatic patients with a
severe stenosis (70-99%) of the internal carotid artery (ICA) in two large randomised
trials.1-4 Subgroups of patients with a 50-69% stenosis may also expect a small
benefit from carotid endarterectomy. The diagnosis of severe stenosis (70-99%),
however, remains crucial for the majority of patients. Increasing degree of stenosis
yielded increasing benefit from surgery, making precise estimation of the degree of
stenosis very important. In the trials the degree of stenosis was assessed with Digital
Subtraction Angiography (DSA), which consequently has become the standard of
reference for selecting patients for carotid surgery. DSA, however, has a risk of
morbidity and mortality, which decreases the potential overall benefit of
endarterectomy. In the literature risk of 4% of transient ischemic attack (TIA) or
minor stroke and 1% of major stroke, and even a small risk of death (<1%) have
been reported.5,6 More recently, a lower rate of neurologic complications due to
DSA was reported: 0.5% for stroke and 0.4% for TIA.7 However, even patients
without apparent neurological complications after DSA have been shown to develop
minor asymptomatic infarctions due to micro-embolisms.8
Over the last decade many diagnostic studies have been published in which
non-invasive diagnostic tests such as Duplex Ultrasound (DUS) and Magnetic
Resonance Angiography (MRA) or combinations of these tests were compared with
DSA.9-19 Two meta-analytic reviews have been published summarising the literature
on the diagnostic performance of DUS and MRA from before 1996. One concluded
that the actual sensitivity and specificity for MRA remain unknown, but that these
are probably lower than reported in the literature because of the presence of
verification bias and because frequently both carotid arteries (symptomatic and
asymptomatic) were included in the analyses.20 The other meta-analysis reported
that non-invasive testing at that point did not appear to be an adequate substitute
for DSA for patients about to have carotid endarterectomy.21 Thereafter the
non-invasive imaging techniques have continued to develop. A review of previous
publications on this topic published between 1993 and 1998, however, criticised
the design of the studies and proposed guidelines for diagnostic studies on carotid
artery imaging.22 Accordingly, a recent review summarising publications from 1990
to 1999, concluded that MRA seemed accurate for selecting patients for carotid
endarterectomy, but that evidence was not very robust because of the heterogeneity
of the studies included.23 The need for a prospective diagnostic study on non-invasive
testing was recently recognized in literature.13
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The objective of this study was to obtain reliable estimates of the diagnostic accuracy
of DUS, MRA, and a combination of these tests compared to DSA as reference
standard to determine whether non-invasive testing can replace DSA in clinical
practice.
Methods
Study population
From January 1997 to November 2000 350 consecutive symptomatic patients
suspected of having carotid artery stenosis were included in a prospective diagnostic
study. Patients underwent DUS, MRA, and DSA examination within a period of
maximally four weeks. All patients had experienced symptoms of carotid artery
disease (transient ischemic attack, minor disabling ischemic stroke, or amaurosis
fugax) in the prior six months. Patients underwent complete neurological examination
within 24 hours before and after DSA to establish possible deficits caused by this
procedure. We excluded patients with contraindications for MRA such as
claustrophobia or metal implants not suitable for MR. Medical history was recorded
from all patients. The decision whether or not to perform carotid endarterectomy
was made in the clinical setting on basis of the DSA examinations. The frequency
of carotid endarterectomy in our study population and the complication rate within
4 weeks after surgery were recorded. Patients were enrolled in the University Medical
Centre Utrecht, University Medical Centre Rotterdam and Enschede Medical Centre.
Our study was approved by a medical ethical committee and all patients gave their
written informed consent. We met recently published quality criteria for design and
presentation of diagnostic studies on carotid artery imaging.22
Diagnostic tests
The degree of stenosis on DUS was determined based on the peak systolic velocity
(PSV) in the proximal part of the ICA. The PSV is considered the most accurate
estimator of the degree of stenosis for DUS.(24) We validated DUS results in a pilot
series before the inclusion of the current study started. By means of receiver operating
characteristics (ROC) curves we previously defined optimal cut-off criteria for the
PSV for different stenosis categories (Table 1). In these criteria the threshold of 70%
stenosis is represented by a PSV of 270 cm/sec.25
DSA was performed by selective positioning of an intra-arterial catheter in both
common carotid arteries. From each carotid bifurcation three projections (lateral,
posteroanterior, and oblique) were acquired. Additional projections of occasionally
performed rotational DSA examinations were not used in the context of this study.
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In all three hospitals MR angiography was performed on a 1.5-Tesla MR imaging
system, using a three-dimensional time-of-flight technique. Postprocessing subvolumes
were generated to visualise each carotid bifurcation and to create Maximum Intensity
Projection (MIP) images. The DSA and MRA protocols have been described in detail
elsewhere.26
Stenosis measurements
The DSA and MRA test results were read by one observer for each hospital (AFJW for
Utrecht and Enschede, AvdL for Rotterdam). The observers were blinded for clinical
information and for the results of the other tests. The DSA and MRA images were
read independently with a period of at least 1 month between the readings.
The observers read the DSA and MRA on printed hard copies. For MRA we only used
MIP images. The grade of stenosis on both DSA and MRA was measured according
to the NASCET criteria.1 The degree of stenosis is defined as the remaining lumen at
the stenosis as percentage of the normal lumen distal to the stenosis. For a valid
comparison with DSA we only used the percentage of stenosis measured on lateral,
posteroanterior, and oblique projections on MRA. The maximum of these three
measurements, both on DSA and MRA, was used in the analyses.26 To estimate the
reproducibility, the percentage of stenosis was measured by two independent observers
(AFJW and PCB) for a representative sample of 170 patients on both DSA and MRA.
Data analysis
Test results of DUS and MRA were first analysed separately compared to the reference
standard DSA.27 The measured stenoses were divided in categories (0-29%, 30-49%,
50-69%, 70-99%, 100%). We included for each patient only the estimate of the
stenosis of the carotid artery on the symptomatic side in the analyses. Results were
Degree of stenosis PSV (cm/sec)
Mild 0-29% < 150
Mild to moderate 30-49% < 190
Moderate 50-69% < 270
Severe 70-99%* 270
Occlusion 100% no detectable flow
Table 1. DUS criteria used to estimate the degree of stenosis based on the peak systolic
velocity (PSV) in the proximal internal carotid artery (ICA). The criteria were defined in a
pilotseries in the University Medical Centre Utrecht before the start of the study24.
* Slow flow in combination with visualised severe stenosis was defined as a 99% stenosis.
>
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interpreted by calculating sensitivity, specificity and positive predictive value,
defining severe stenosis (70-99%) on DSA as a positive test result. Secondly, DUS
and MRA results were combined and considered as a combination test. We analysed
the part in which DUS and MRA were in agreement concerning the diagnosis of
severe stenosis (70-99%) as a separate group. The combined results of this group
were again compared with DSA. Kappa statistics were calculated for the DSA and
MRA results of the 170 patients read by two observers.
Results
Study population
Of the 350 patients included 249 patients were enrolled in Utrecht, 62 in Rotterdam
and 39 in Enschede. The baseline characteristics and relevant medical history are
listed in Table 2. To assess generalizability we monitored the reasons for exclusion
in one hospital (Utrecht). In this hospital, during the study period, 297 patients
underwent DSA to decide on carotid endarterectomy. Of this total 84% (249 patients)
were included in the study. Reasons for exclusion were claustrophobia in 3.4%,
metal implant not suitable for MR in 3.0% and refusal to participate in the study in
8.8%. Reasons for refusal were mostly stress for planned surgery or participation in
other studies. Baseline characteristics of the 48 excluded patients did not differ
significantly from the included population.
From the total of 350 patients included in the three hospitals the following numbers
of stenosis measurements from the symptomatic side were interpretable and could
be included in the analyses: DSA 323, DUS 330, MRA 295. Missing values were
caused by the following reasons: sometimes it was not feasible to perform all three
tests prior to surgery, withdrawal of patients from the study after one or two tests,
and the test was not always correctly performed according to our study protocol
(see methods). In DUS occasionally the PSV was not measured. Finally it was
impossible to measure stenosis because of poor quality and reliability of the MRA
recordings in 10 patients, of the DSA recordings in 7 patients. The complication rate
of DSA in our series was 1.4% minor stroke (95%CI, 0.1-3.3%), 0.3% major stroke
(95%CI, 0.0-1.6%) and 0.6% mortality (95%CI, 0.1-2.0%). Two-hundred-twenty
patients underwent carotid endarterectomy (63%). The complication rate of surgery
(within 4 weeks) was 3.2% minor stroke (95%CI, 1.3%-6.5%) and 0.5% major stroke
(95%CI, 0.0%-2.5%).
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Diagnostic test results
In Table 3 the test results of DUS are presented with DSA as reference. DUS analysed
with previously defined PSV criteria resulted in a sensitivity of 87.5% (95%CI, 82.1%-
92.9%) and a specificity of 75.7% (95%CI, 69.3%-82.2%) in identifying severe ICA
stenosis (70-99%). Stenosis measurements (NASCET) on MRA compared with DSA
yielded a sensitivity of 92.2% (95%CI, 86.2%-96.2%) and a specificity of 75.7%
(95%CI, 68.6%-82.5%) (Table 4).
Characteristics (N=350)
Mean (range) age (y)
Male/Female (%)
Symptoms* (%)
Amaurosis fugax / retinal
Transient ischemic attack
Stroke
Supply area (%)
Right carotid artery
Left carotid artery
Basilar artery
Unknown
Previous carotid endarterectomy (%)
Hypertension (%)
Diabetes (%)
Cardiac history (%)
Angina
Myocardial infarction
Heart failure
Bypass-surgery or PTCA
Peripheral arterial disease (%)
Claudication
Surgery or PTA
Smoking (%)
Smoker
Ex-smoker
67 {39 88}
76/24
22
42
36
46
52
1
1
4
49
15
18
16
6
11
15
8
49
34
Table 2. Baseline characteristics study population
* 0-6 months prior to inclusion
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For DUS the positive predictive value was 75.4% (95%CI, 68.9%-82.0%) and the
negative predictive value was 87.7% (95%CI, 82.3%-93.0%). For MRA these values
were 76.3% (95%CI, 69.6%-83.0%) and 92.0% (95%CI, 85.8%-96.1%). Both DUS
and MRA had a tendency to overestimate the degree of stenosis compared with
DSA. In 274 patients stenosis measurements from all three test results (DSA, DUS
and MRA) were available. In 229 of these patients (84%) DUS and MRA were in
agreement about diagnosing severe stenosis (70-99%). In this subgroup, with
agreement between the two modalities, the combination of MRA and DUS results
(i.e. considering them as one single test) gave a sensitivity of 96.3% (95%CI, 90.8%-
99.0%) and a specificity of 80.2% (95%CI, 73.1%-87.3%) for identifying severe
stenosis (Table 5).
Table 3. Categorised stenosis measurements of the internal carotid artery (ICA) of symptomatic
patients (n=313); Duplex ultrasound (DUS) versus Digital subtraction angiography (DSA).
Stenosis categories DSA
0-29% 30-49% 50-69% 70-99% 100% Total
0-29% 15 5 2 22
Stenosis 30-49% 6 6 7 19
Categories 50-69% 1 5 22 16 44
DUS 70-99% 7 30 126 4 167
100% 2 59 61
Total 22 23 61 144 63 313
Table 4. Categorised stenosis measurements of the internal carotid artery (ICA) of symptomatic
patients (n=281); Magnetic resonance angiography versus Digital subtraction angiography
(DSA).
Stenosis categories DSA
0-29% 30-49% 50-69% 70-99% 100% Total
0-29% 17 3 2 22
Stenosis 30-49% 2 5 4 1 12
Categories 50-69% 7 20 6 33
MRA 70-99% 5 29 119 3 156
100% 3 55 58
Total 19 20 55 129 58 281
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The positive predictive value for the combination was 81.2% (95%CI, 74.5%-88.0%), the
negative predictive value was 96.0% (90.2%-98.9%). In this combination strategy there also
is a tendency to overestimate the stenosis compared with the reference test DSA.
In all 24 cases of overestimation in this combination strategy, based on concordant results,
DSA categorised the stenosis only one category lower as 50-69%. The diagnostic test results
of the single tests and combination are listed in Table 6. Interobserver variability for DSA and
MRA was very good and similar for both tests (kappa 0.79 (95%CI, 0.74-0.84) for DSA and
0.79 (95%CI, 0.73-0.84) for MRA).
Table 6. Diagnostic accuracies of the non-invasive tests Duplex ultrasound (DUS), Magnetic
resonance angiography (MRA), and their combination strategy (DUS & MRA) in recognising
severe stenosis (70-99%) in the internal carotid artery (ICA), using Digital subtraction
angiography (DSA) as the standard of reference.
Sensitivity Specificity
Positive predictive
value
Negative predictive
value
N % (95%CI) % (95%CI) % (95%CI) % (95%CI)
DUS 313 87.5 (82.1-92.9) 75.7 (69.3-82.2) 75.4 (68.9-82.0) 87.7 (82.3-93.0)
MRA 281 92.2 (86.2-96.2) 75.7 (68.2-96.2) 76.3 (69.6-83.0) 92.0 (85.8-96.1)
DUS=MRA 229 96.3 (90.8-99.0) 80.2 (73.1-87.3) 81.2 (74.5-88.0) 96.0 (90.2-98.9)
Table 5. Stenosis measurements of the internal carotid artery (ICA) of symptomatic patients
(n=229) in which Duplex ultrasound (DUS) and Magnetic resonance angiography (MRA)
were in agreement (84% of patients). The stenosis measurements are divided into two categories:
70-99% (severe stenosis) and <70% or occlusion, Digital subtraction angiography is used as
standard of reference.
Result DSA
<70% or 100% 70-99% Total
<70% or 100% 97 4 101Result
Combination strategy
MRA=DUS 70-99% 24 104 128
Total 121 108 229
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Figure 1. Male (age 64): Digital subtraction angiography on the left (DSA) and
time-of-flight magnetic resonance angiography on the right (MRA) both show a
moderate stenosis (50-69%) in the internal carotid artery (ICA). The peak systolic
velocity (PSV) at Duplex ultrasound (DUS) examination was 250 cm/sec.
Figure 2. Male (age 74): Digital subtraction angiography on the left (DSA) and
time-of-flight magnetic resonance angiography on the right (MRA) both show a
severe stenosis (70-99%) in the internal carotid artery (ICA). The peak systolic velocity
(PSV) at Duplex ultrasound (DUS) examination was 520 cm/sec
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Discussion
Both DUS and MRA seem accurate diagnostic tests to detect carotid artery stenosis.
In combining test results, agreement in diagnosing severe stenosis (70-99%)
between DUS and MRA (84% of the patients) yielded a high sensitivity and specificity.
Both DUS and MRA have the tendency to overestimate stenosis compared with the
standard of reference DSA.
DUS is commonly used to screen patients with possible carotid artery disease,11 but
has also been suggested as the sole test to select patients for carotid endarterectomy.12,16
This technique, however, has limitations such as variability in optimal thresholds,25
possible effect of verification bias,28 and limited morphological information. MRA
can also be used as non-invasive test to diagnose carotid artery stenosis.20,21 MRA
provides more morphological information without exposure to the risks of DSA. At
the start of our study the time-of-flight technique was the state-of-the-art technique
for MRA. MRA techniques, however, have improved during the period of our study.
The introduction of contrast-enhanced MRA (CE-MRA) may further add to the
development.29,30 CE-MRA provides additional morphological information about the
origin of the carotid arteries and intra-cranial vessels and the effect of flow related
artefacts occurring with the time-of-flight technique is diminished. To date, however,
only a few studies have been published reporting the results of contrast-enhanced
MRA validated against DSA in small cohorts, precluding a precise estimate of its
accuracy.23 For a valid throughout evaluation of a new imaging technique an
adequately powered study is mandatory.22 However, such a study is likely to be
large, expensive and time-consuming, precluding application of the newest imaging
protocols. Recently, however, we also introduced CE-MRA in our clinical setting
supplemental to the time-of-flight protocol, allowing us to estimate its accuracy in
a subgroup of patients.
Irrespective of the use of intravenous contrast, very good accuracies have been
published for MRA if used in combination with DUS.13,14,17,19 Most of the studies on
this subject, however, did not meet all standard criteria for design and reporting of
the diagnostic tests.22 The number of patients that underwent MRA in these series
was relatively small and often the data were recorded retrospectively, introducing
the risk of observer bias.
Our reported accuracies of DUS and MRA might seem relatively low compared
with other studies.11-21 However, we feel that our prospective design added to valid
and unbiased estimates. Another explanation is the fact that we only included the
test results of the carotid artery on the symptomatic side in the analyses, yielding
lower accuracies. Furthermore, since it is the symptomatic artery for which a decision
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on performing endarterectomy needs to be made, excluding the asymptomatic side
reflects clinical practice. Previously published reports generally also included the
asymptomatic side, which was not suspected of having stenosis on DUS. The majority
of the arteries on the asymptomatic side show a stenosis percentage far below the
70% threshold or no stenosis at all, making it more likely for the different tests to
agree. In this way the number of true negative results inflates and thus specificity
may be overestimated in those studies. In our data the specificities increased by
10.7% for DUS and 14.2% for MRA if the stenosis measurements of all arteries were
included.
Furthermore, it is important to realise that diagnostic testing is limited by some
general methodological limitations. In a diagnostic study a new test by definition
never exactly agrees with the reference test.27 Even if readings of the reference test
itself were to be repeated there would always be certain variability in results.
The aim of a diagnostic study should not be to achieve the highest possible accuracy.
The more relevant question is to what degree a new test under investigation differs
from the reference test and what implications this has on the outcome of clinical
decisions for individual patients. For this purpose the most realistic estimate of the
accuracy is requested. The results should be the guideline in deciding on diagnostic
strategies in the clinical setting. Furthermore, to make the right policy decisions
from a societal perspective, additionally to a valid estimate of the accuracy of
non-invasive testing, a cost-effectiveness should be taken into account.
An additional point of interest is the fact that both DUS and MRA had the tendency
to overestimate the degree of stenosis. In DUS verification bias may have played a
role. Verification bias may exist if the decision to perform the gold standard
procedure depends on the results of the test under investigation.28 The sensitivity
may be lower, and specificity higher, after adjustment for this bias. In our study,
patients were often screened with DUS in the clinical setting prior to inclusion.
Based on ethical grounds inclusion in the study depended on the decision of the
clinician to perform DSA, if CEA was considered. Accuracy of DUS related to the
70% stenosis threshold was estimated afterwards among patients selected for DSA.
The tabulations show that all categories of degree of stenosis are present, although
the majority has a moderate or severe stenosis. In our opinion, however, it is precisely
this selected group of patients, suspected of having ICA stenosis at DUS examination,
that constitutes the right domain to answer our study objective, reflecting the
population for which the decision on surgery has to be made in daily clinical practice.
MRA may also overestimate stenosis in comparison with DSA. Overestimation on
MRA may occur when all twelve available projections are used for the stenosis
measurements, and subsequently compared with DSA where stenosis is often
measured in only three directions (lateral, posteroanterior, and oblique).26
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In our study, with regard to the endarterectomy trials, in all patients we assessed the
degree of stenosis on DSA using the three standard directions, and therefore we used
only the same three corresponding projections on MRA. Nevertheless, overestimation
still occurred. Although we have interpreted our findings as overestimation on MRA,
it is very well possible that DSA underestimates the true degree of stenosis and that
new (three-dimensional) techniques can estimate the degree of stenosis more
precisely.
Using the combination strategy of DUS and MRA yielded the highest accuracy.
An important finding was that in all cases in which both DUS and MRA overestimated
the stenosis (and agreed carotid endarterectomy was indicated) the stenosis fell into
the 50-69% category according to DSA. Based on the recently published results
from NASCET and ECST these patients still have limited benefit from carotid
endarterectomy.3,4 It is expected that in the near future additional evidence will
come available on which patients may expect most benefit from carotid
endarterectomy in the 50-69% stenosis category.31,32
In our opinion, in a non-invasive diagnostic strategy, both DUS and MRA should
subsequently be performed. In clinical practice, based on the results of this diagnostic
studie, we no longer perform DSA routinely in all symptomatic patients suspected
of having a carotid artery stenosis after screening with DUS. We first perform MRA
examination instead. However, DSA should still be considered in those cases where
considerable doubt persists about the indication for carotid endarterectomy after
DUS and MRA examination, i.e. in case of clear disagreement between these two
tests, or when additional morphological information about origin of the common
carotid artery or about intracranial vessels is necessary to make the right decision
on performing endarterectomy. In conclusion, based on the diagnostic performance,
DSA can be replaced by the combination of DUS and MRA in the majority of patients.
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Abstract
Background:
Potentially hazardous Digital Subtraction Angiography (DSA) is used to decide on
carotid endarterectomy in symptomatic patients, i.e., presenting with TIA, amaurosis
fugax or minor stroke. The merits of non-invasive alternatives are unknown.
Objective:
To examine the cost-effectiveness of diagnostic strategies for carotid artery
stenosis.
Design:
Sensitivity and specificity of Duplex UltraSound (DUS), Magnetic Resonance
Angiography (MRA) or combinations were compared to the reference standard DSA
in a blinded prospective consecutive cohort study. From 1997 until 2000, 350
symptomatic patients pre-selected with DUS that gave informed consent to undergo
MRA and DSA were enrolled in a multi-center study with one general and two
university hospitals. In parallel a study on the costs of the diagnostic tests and
carotid endarterectomy was performed. Additional data on long-term costs, survival,
and quality of life related to stroke were retrieved from the published literature.
Long term outcomes required for cost-effectiveness analysis (CEA) were assessed by
means of a Markov model. Finally, a comprehensive CEA was performed using a
decision model.
Data Sources:
Clinical study results and published literature.
Target Population: Cost-effectiveness was assessed for a hypothetical cohort of 55
year old symptomatic male patients.
Time Horizon:
Lifetime.
Perspective:
Societal.
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Interventions:
DUS, MRA, DSA and combinations.
Main Outcomes:
Sensitivity, specificity and incremental cost-effectiveness ratios (CE ratio) in terms
of costs per quality adjusted life year (QALY) gained.
Results of Base-Case analysis:
DUS had  a sensitivity of 88%  and specificity of 76%.  For MRA these values were
92% and 76%, respectively. Combining DUS and MRA in case of concordance
yielded superior results (96% and 80%). The cost-effectiveness analysis revealed
that DUS alone would be the optimal strategy. Adding MRA may marginally increase
the QALY gain but costs could be considered prohibitive. DSA in cases where DUS
and MRA are discordant, and DUS or MRA followed by DSA, would result in QALY
loss due to complications and increased costs, i.e., were dominated strategies.
Results of Sensitivity Analyses:
Although the expected QALY gains and costs varied, the order of strategies did not
change.
Conclusion:
In symptomatic patients DUS without additional imaging is the optimal diagnostic
strategy to select patients for carotid endarterectomy in terms of
cost-effectiveness. A combination strategy of DUS and MRA to select patients for
carotid endarterectomy yields a slight benefit in terms of clinical outcome, however,
at relatively high costs.
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Introduction
Several large randomized trials such as the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) and the European Carotid Surgery Trial (ECST) have
shown that patients with symptomatic carotid artery stenosis, i.e., suffering from
TIA or minor stroke, may benefit from carotid endarterectomy. Particularly, patients
with demonstrated severe stenosis (70-99%) of the internal carotid artery can expect
beneficial effects.1,2 More recent results show that patients with moderate stenosis
(50-69%) may also benefit from surgery.3 However, complications resulting from
diagnostic testing or operation limit the margin for benefit of carotid endarterectomy
as compared to medical treatment, whereas patients with low grade stenosis (<50%)
are better off treated medically with aspirin therapy. Accordingly, a safe and reliable
estimate of the degree of stenosis to set the indication for operation is crucial.
In the NACSET and the ECST the degree of stenosis was confirmed by means of
Digital Subtraction Angiography (DSA), which has since become the standard of
reference. DSA, however, is associated with a 4% risk of transient ischemic attack
(TIA) or minor stroke, a 1% risk of major stroke, and even a small (<1%) risk of
death.4 Also, silent infarctions were demonstrated in patients who did not show a
clear neurological deficit after DSA.5 Exposing all patients to a hazardous diagnostic
test to lower the future risk of stroke or death for a sub-group seems paradoxical.
The potential benefit for symptomatic patients is certainly diminished by the invasive
nature of DSA. This has increasingly been recognized over the last decade.
Nowadays, non-invasive diagnostic tests are repeatedly propagated as a replacement
of DSA. Recent diagnostic studies and even some reviews have appeared on Duplex
ultrasound (DUS) and Magnetic Resonance Angiography (MRA). Promising results
have been reported which have led to implementation of non-invasive tests to
select patients for surgery in some institutions.6-12 However, critical notes on the
moderate test results of the non-invasive alternatives have also been made.13
Adding further to the discussion, combination strategies of DUS and MRA have
been introduced. A combination of initial DUS for screening of stenosis and/or a
subsequent MRA test to diagnose severe stenosis ( > 70% stenosis) may be considered
sufficient to decide to operate. Also, in case of discordant results of DUS and MRA
clinicians may feel compelled to perform DSA. Likewise, in accordance with
recent standard practice, routine confirmation of severe stenosis by means of DSA is
an option. Finally, taking into account variable cut-off points for DUS as well as
MRA numerous other test strategies are conceivable.
However, despite seemingly obvious advantages of non-invasive testing the actual
impact in terms of strokes prevented, life years gained or cost-effectiveness remains
to be determined. Accordingly, the purpose of the current study was to assess
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diagnostic accuracy and long term implications in terms of longevity, quality adjusted
life years (QALY), costs, and incremental cost-effectiveness ratios (CE ratio) of various
non-invasive diagnostic test modalities and the current combination of DUS and
subsequent DSA in case of an indication of significant stenosis in patients with
symptomatic carotid artery stenosis.
Methods
Test evaluation
A blinded multi-center prospective consecutive cohort study was performed to assess
the diagnostic accuracy of Duplex ultrasound (DUS) examination, Magnetic
Resonance Angiography (MRA) and combinations of these tests in comparison with
Digital Subtraction Angiography (DSA) in diagnosing carotid artery stenosis in
symptomatic patients.14 Briefly, 350 patients with manifest cerebrovascular
symptoms, i.e., TIA or minor stroke, who gave informed consent were enrolled.
Of all patients considered eligible 15% could or would not participate (3.4% had
claustrophobia, 3.0% had a metal implant and 8.8% refused). Patients underwent
DUS and if significant stenosis was suspected and if they were considered potential
candidates for operation, MRA and DSA were subsequently performed.
Conform the results obtained in NASCET and ECST patients with 70 - 99% stenosis
(NASCET criteria) were offered carotid endarterectomy.3,15 Based on the data
pertaining to the carotids ipsilateral to the symptoms sensitivity and specificity of
DUS, MRA, and various combinations of these tests were calculated using DSA as
the reference standard.
Cost analysis
In parallel with the clinical study the costs of the diagnostic tests, if applicable
including hospitalization, and of carotid endarterectomy were estimated from a
societal perspective in terms of 1998 € (€ 1 = NFL 2.20371 ~ US$ 1.11 (1998)).
Actual costs were estimated which included the costs of personnel, equipment,
materials, maintenance, housing, cleaning, administration and overhead.16
Cost data were recorded in one university hospital and one general hospital.
Based on the distribution of patients across various types of hospitals in the Netherlands
weighted averages were calculated. Additional cost estimates for the Dutch setting
were derived from existing literature.17-20 The actual short and long term costs of
minor and major stroke, including diagnostic work-up, medication, hospitalization,
rehabilitation and nursing home admission were previously reported. Reports on
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costs pertaining to TIA or dying were not available. These were estimated with the
input from experts in the field taking into account the costs of possible diagnostic
testing, consultation of a general practitioner and/or specialist, diagnostic
examination and emergency hospitalization.
Cost-effectiveness analysis
The cost-effectiveness outcomes of various diagnostic strategies were compared
with a decision model. Both short and long term outcomes were accounted for by
extrapolating to lifetime outcomes from clinical trial data.21
First, a comprehensive decision model was developed taking into account various
diagnostic tests and combinations of tests. All tests were assessed as a stand alone
subsequent to a low threshold screening DUS. Of all eligible patients, however,
11.5% did not undergo MRA because of contra-indications or claustrophobia and
thus required another imaging test. For most (combination) strategies considered we
assumed that these patients would instead undergo DSA. In combination strategies
DUS screening and subsequent decisive MRA were evaluated, as well as relying on
either one or the other test positive. We also explored relying on the results of DUS
in patients unable to undergo MRA, rather than performing DSA. As DUS already
has good sensitivity and specificity the latter strategy would introduce only a limited
error yet would save DSA in 11.5% of the patients. Also, stand alone as well as
combination strategies were considered in combination with DSA to rule in or rule
out severe (>70%) stenosis. Finally, several cut-off values for a positive result for
DUS and MRA were evaluated, as well as a cut-off for endarterectomy, i.e., >50%
or >70% stenosis. All in all 62 strategies were compared.
The degree of carotid artery stenosis was categorized: 0-49%, 50-69%, 70-99% stenosis
and occlusion. Also, the initial symptoms (TIA or minor stroke), as well as
complications occurring as a result of DSA or operation were accounted for.
Next, a Markov model was developed to extrapolate and evaluate the long-term
outcome of the diagnostic work-up and subsequent treatment offered. In accordance
with current Dutch guidelines time preference was accounted for using a 4% discount
rate for costs and effects.22 Multiple (Markov) health states following the initial
diagnosis and treatment, i.e., reflecting degree of stenosis, treatment offered, possible
stroke and vital status were modeled. Besides optimal medical care including aspirin,
in symptomatic patients an operation is generally considered indicated for 70-99%
stenosis. According to recent results, however, patients with a
50-69% stenosis may also expect limited benefit of operation, particularly, men
with TIA or minor stroke. In lower grade stenosis (less than 50%) optimal medical
care alone is recommended. In the Markov model optimal medical care as well as
endarterectomy were taken into account for the four categories of stenosis.
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In addition, patients with minor stroke were assumed to incur costs and experience
limited disability at the onset. Therefore, the initial event, i.e., TIA or minor stroke
was also distinguished in the model. Moreover, prognosis depends on the extent of
the underlying vascular disorder. In symptomatic patients with low grade stenosis
the risk of future events is lowest whereas in patients with high grade stenosis the
risk is highest, particularly early after the initial event. The associated hazard rates
used in the model were derived from the existing literature and if not reported in
detail refined with the help of experts.3 (A table presenting the hazards over time is
available on request from the corresponding author.)
With regard to future cerebrovascular events carotid endarterectomy will
predominantly affect the prognosis related to the symptomatic carotid artery.
Accordingly, only ipsilateral cerebro-vascular events were modeled.
Fatal contra-lateral cerebrovascular events and other cardiovascular mortality,
however, were accounted for by adjusting age and sex specific mortality rates for
the Dutch population with a disease specific rate ratio.23
Utility weights for the relevant health states well, minor stroke, major stroke and
death were derived from the existing literature and were 1.0, 0.8, 0.2 and 0.0,
respectively.24,25 For TIA a one time disutility equivalent to 2 days with major stroke
was assumed. The Markov model was used to estimate long term outcomes in terms
of life years, QALYs, and costs for all possible health states assuming these would
pertain to a symptomatic 55 year old male patient. The results obtained by means
of the ‘prognostic’ Markov model were used as input for the ‘diagnosis and treatment’
decision model to obtain an overall comparison of the diagnostic strategies. Expected
life time costs and QALYs related to the various health states resulting from the
diagnostic strategies were compared using the decision model. Similarly, incremental
cost-effectiveness ratios for the successive strategies were calculated. For strategies
resulting in increased costs and worse outcomes in terms of QALYs compared to
alternative strategies, reporting an incremental CE ratio becomes redundant, i.e.,
inferior strategies are so-called ‘dominated’.  Sensitivity analyses were performed
to evaluate the impact of variability of the estimates and assumptions used in the
models. Tables 1 and 2 present detailed information on the variables evaluated
including the ranges over which the sensitivity analyses were conducted.
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Variable Point estimate Range Source
Age at diagnosis (years) 55 45 to 65
Utility health states (major and minor 0.2 and 0.8 0.1 to 0.3 and 0.7 to 0.9 (24;25;25)
Discount rate 0.04 0.0 to 0.10 (16)
Probability stroke DSA 0.03 0.01 to 0.09 Current study,(14)
Probability dead DSA 0.001 0.0003 to 0.003 Current study,
Probability stroke carotid endarterectomy 0.055 0.015 to 0.15 Current study,
Probability dead carotid endarterectomy 0.0106 0.003 to 0.03 Current study,
Proportion MRA impossible 0.11 0.03 to 0.30 Current study
Proportion major stroke in case of stroke 0.33 0.10 to 0.66 (3;15)
Table 1. Variables, their point estimates and ranges used in the sensitivity analysis.
Table 2.  Cost estimates used in Markov and- or decision models
* Includes hospitalisation.
# Excludes contrast enhancement.
¶ Limited diagnostic work-up and consultation by general practitioner assumed, whereas, consultation by general
practitioner, specialist and diagnostic tests were recognised in potential candidates for operation, i.e., treated medically.
† Consultation by general practitioner, specialist, and for half the patients emergency transportation and admittance to ICU or
general ward and diagnostic tests were accounted for.
Cost components Source
Duplex ultrasound 48 96 Cost study
Digital subtraction angiography* 1,053 2,106 Cost study
Magnetic resonance angiography# 231 461 Cost study
Carotid endarterectomy 2,759 5,518 Cost study
Minor stroke procedure related 3,654 7,308 (17-20)
TIA after CEA or major stroke¶ 70 140 Expert opinion
TIA in patients treated medically 1,052 2,104 Expert opinion
Minor stroke 1st year 5,092 10,185 (17-20)
Minor stroke subsequent years 871 1,743 (17-20)
Major stroke 1st year 29,039 58,078 (17-20)
Major stroke subsequent years 16,956 33,912 (17-20)
Dying† 2,166 4,332 Expert opinion
8,478 -
1,083 -
526 -
2,546 -
436 -
14,520 -
115 -
1,379 -
1,827 -
35 -
Cost estimates used (€) Range (€)
24 -
526 -
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Results
Diagnostic performance
Compared to the standard of reference (DSA) both DUS and MRA proved to be
accurate tests. At various cut-off points for peak systolic velocity,26 the sensitivity of
DUS varied between 87.5% and 98.6% and specificity between 59.2% and 75.7%
for the diagnosis 70-99% carotid stenosis. Similar calculations for MRA alone yielded
comparable values between 92.2% and 96.9% and 57.9% and 75.7% respectively.
As expected, varying the threshold shifted the test characteristic; at lower thresholds
sensitivity increased whereas specificity decreased and vice versa. The combination
DUS as a low threshold screening test and MRA as a definite test, however, was
superior with a sensitivity for the overall strategy of 92.1% and specificity of 78.4%.
A combination considered positive either if DUS or MRA indicate a stenosis of
70-99% further improved sensitivity to 98.4%, yet the specificity was only 54.0%.
Adding DSA in case of discordant test results also improved sensitivity to 98.4%.
The latter, however, would imply that 16% of the patients would have to undergo
DSA because of discordant results in addition to the 11.5% that were unable to
undergo MRA at all. Other strategies also implied that varying proportions of the
patients would have to undergo DSA, i.e., up to 75% or 100% in the reference
strategy (Table 3, 4th column).
Corresponding calculations for the individual tests assuming a 50% stenosis threshold
for the indication to operate resulted in small decreases in sensitivity, i.e., up to
about 5%, while substantially increasing specificity by approximately 25%. For the
combination strategies the effects on the test characteristics were similar but smal-
ler, i.e., a 1% decrease in sensitivity and 10% increase in specificity.
A final finding was that all non-invasive tests, i.e., DUS, MRA and the combinations,
tended to somewhat overestimate the stenosis as compared to DSA. This implies
that if DSA is not used to confirm the non-invasive test results some patients (in the
worst case up to about 26%) may be considered ‘overtreated’ (Table 3, right
column).
Cost analysis
For DUS, MRA, DSA, and CEA the costs estimated in 1998 in the university hospital
and in the general hospital did not differ substantially (Table 2). The actual costs
associated with stroke and subsequent rehabilitation were retrieved from the
literature. Costs incurred after TIA or dying were estimated with the help of experts
(Table 2).
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Subsequently, various diagnostic strategies were compared in terms of costs, effects
(life years and QALYs) and incremental cost-effectiveness ratios (costs per LY and
costs per QALY gained). In terms of costs per LY gained DUS as stand-alone test had
the lowest CE ratio. The combination strategy that results from adding MRA as a
definite test marginally improves longevity yet at increased costs (incremental CE
ratio € 33,400/LY gained). Many other strategies had lower expected LY and higher
costs, i.e., were dominated, or were dominated by subsequently more efficient
strategies such as a high threshold combination of DUS and MRA without DSA, and
high threshold DUS confirmed by DSA. The latter strategies, however, had quite
unfavorable incremental CE ratios (respectively > € 79,000 and > 660,000 /LY
gained) compared to the strategies above.
Model based cost-effectiveness
First the remaining life expectancy of a 55-year-old symptomatic male patient with
various degrees of carotid artery stenosis and either TIA, minor stroke or major stroke
was assessed (Table 4). Similarly, by taking into account the utility weights and lifetime cost
estimates for the various health states the expected QALYs and overall costs were estimated
(Table 4).
Outcomes diagnostic work-up Life years QALYs Lifetime costs ( )
Stenosis 0-49%, treated medically (ASA) after TIA 14.0 12.9 20,965
Stenosis 50-69%, treated medically (ASA) after TIA 14.0 12.5 26,646
Stenosis 70-99%, treated medically (ASA) after TIA 13.9 11.9 36,582
Occlusion, treated medically (ASA) after TIA¶ 13.9 13.9 2,161
Stenosis 0-49%, treated medically (ASA) after minor stroke* 14.0 10.6 30,800
Stenosis 50-69%, treated medically (ASA) after minor stroke* 14.0 10.4 35,841
Stenosis 70-99%, treated medically (ASA) after minor stroke* 13.9 10.1 44,400
Occlusion, treated medically (ASA) after minor stroke¶ 13.9 11.1 14,284
Carotid endarterectomy after TIA 14.0 13.0 18,898
Carotid endarterectomy after minor stroke* 14.0 10.7 28,923
Major stroke treated medically (ASA)# 13.9 2.8 238,162
Dead 0.0 0.0 0
Table 4. Outcomes after diagnostic work-up and initial treatment with corresponding expected
life years, QALYs, and lifetime costs†.
†Estimates were obtained by means of the prognostic Markov model
ASA = acetyl salicylic acid, TIA = transient ischemic attack,
¶ Occlusion is assumed not to result in further ipsilateral events; contralateral events were not
taken into account.
* Minor stroke as initial event or as a result of diagnostic work-up or treatment.
# Regardless of underlying stenosis no further treatment and serious prognosis assumed.
€
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27.0
27.5
28.0
28.5
29.0
29.5
30.0
30.5
31.0
11.22 11.24 11.26 11.28 11.30 11.32 11.34
Costs (x1000 )
QALYs
DUS alone
DUS combined with MRA, MRA impossible rely on DUS, discordant test results rely on MRA
DUS combined with MRA, either positive operate, MRA impossible rely on DUS
MRA alone, MRA impossible DSA
DUS combined with MRA, MRA impossible do DSA, discordant test do DSA
DUS combined with MRA, MRA impossible do DSA, discordant tests rely on MRA
DUS, positive test operate, negative test DSA to exclude serious stenosis
MRA, positive test operate, negative or MRA impossible DSA to exclude serious stenosis
DUS (strict cut-off) combined with DSA, positive test confirm by DSA
DUS combined with MRA, either positive or MRA impossible, DSA to confirm
MRA combined with DSA, impossible or positive test confirm by DSA
DUS combined with MRA, positive test confirm by DSA, MRA impossible or discordant do DSA
DSA all (reference strategy)
Figure 1. Expected life-time costs vs life-time QALYs.
€
The results of the cost-effectiveness analyses in terms of costs per QALY gained had
virtually similar implications (Figure 1). Again DUS as a stand-alone test was the
most cost-effective test, i.e., would on average yield 11.33 QALYs at € 27,400.
DUS in combination with MRA as a decisive test or relying on the initial DUS if
MRA appeared impossible would result in a marginal gain in QALYs. However,
having all patients undergoing MRA in addition to DUS  would imply extra costs
thus resulting in a prohibitive incremental cost-effectiveness ratio (> € 1,500,000
per QALY gained). All other strategies were less effective and more expensive, thus
dominated. Notably, performing a DSA in patients who could not undergo MRA, or
if DUS and MRA yielded discrepant results would result in QALY loss and increased
costs.
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The strategy of DUS as a screening test and subsequent DSA if a severe stenosis is
suspected was also clearly dominated, i.e. would imply € 1,800 additional costs
and 0.06 QALY loss as compared to DUS alone. The results of the latter analysis
were clustered according to use of diagnostic tests or combinations of tests and are
presented in figure 1.
The sensitivity analyses performed showed that the results were robust.
We took into account various strategies at varying cut off levels for the individual
tests, i.e., criteria for a positive test result, which in fact represent sensitivity analy-
ses on matching combinations of sensitivity and specificity. This resulted in moving
along the ‘line’ observed in figure 1 but the order of strategies remained the same.
The utilities for minor and major stroke were varied by + or – 0.1 which did not alter
the order of preference. Similarly, the age of symptomatic patients was varied
between 45 and 65 years, and the discount rate was varied between 0 and 10%,
which had no impact on the order of preference. The cost-estimates of the diagnostic
tests were varied by a factor 0.5 to 2 and did not alter the order of preference among
the strategies. As expected, increasing the cost of MRA resulted in even more
unfavorable incremental CE ratios. Likewise, the costs of operation did not
substantially alter the results. However, at high cost of operation (> € 5,900) strategies
using higher threshold values for positive test results, i.e., more strict strategies
implying lower sensitivity and higher specificity, became slightly more favorable.
As for the likelihood of complications associated with DSA these were varied by a
factor 0.3 to 3 and little effect was observed. At very low stroke rates (<0.01) the
incremental CE ratio decreased substantially. The likelihood of complications arising
from carotid endarterectomy were varied by a factor 0.3 to 3 and did not change the
order of preference.  At low peri-procedural mortality (<0.01) and stroke rates (<0.05)
DUS dominated all other strategies. At high stroke rates (>0.10) strategies with high
threshold values for positive test results became favorable. The proportion of patients
unfit or unwilling to undergo MRA (varied over the range 0.03 to 0.3) had no impact
on the order of strategies. At high values the incremental CE ratios for the combination
strategies became increasingly unfavourable. Similarly, the proportion of patients
suffering from major stroke had little effect. Only at implausibly high likelihood of
major stroke (>0.5), however, the combination strategy reached an acceptable
incremental CE ratio (< € 25,000/QALY gained).
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Discussion
This study shows that for patients with symptomatic carotid artery stenosis DUS as a
stand-alone test to establish a final diagnosis and treatment plan is the most cost-
effective strategy. A combination strategy of DUS and MRA to select patients for
carotid endarterectomy yields a slight benefit in terms of clinical outcome, however,
at high additional costs. At various thresholds, i.e., sensitivities, these findings
changed only marginally. At higher thresholds specificity increased thus resulting
in a somewhat lower proportion that would undergo carotid endarterectomy. Under
all realistic assumptions our results remained the same.
These findings emerged despite the fact that the non-invasive tests, and especially
DUS, overestimated the grade of carotid stenosis. The latter is easily explained by
recalling that patients with moderate stenosis may also benefit from operation,
particularly men with TIA or minor stroke. Accordingly, the warnings expressed by
others on the apparent misclassification and ‘overtreatment’ that may arise from
using a non-perfect test may not be clinically relevant.27 A further finding was that
if DUS would be used as a screening test, followed by MRA as a definite test, a
minimal QALY gain can be expected because some false positive cases with minor
stenosis expecting minor or no benefit are likely to be ‘filtered out’. However, the
incremental costs appeared considerable and thus the incremental cost-effectiveness
would be quite unfavorable. At various thresholds for DUS and MRA this result did
not change. Also, the sensitivity analyses showed that the order in terms of
efficiency was barely altered by varying the likelihood of complications resulting
from DSA or operation nor by the cost estimates. The conventional approach to
always use DSA as a final test after DUS was clearly dominated, i.e., the prevailing
strategy implies a loss of QALYs and increased costs. Similarly, various other
combinations including DSA, e.g., using DSA in case of a discrepancy between
DUS and MRA, or to confirm or rule out serious stenosis, were dominated.
A comparable study by Kent et al. addressing exactly the same issue was published
before results on intermediate grade stenosis and long term results of the NASCET
were available.8 They used a less complex model and assessed fewer strategies.
A combination strategy of DUS and MRA including DSA in case of discordant DUS
and MRA was found favourable in terms of effect with an acceptable incremental
CE ratio. Some essential differences in the assumptions made for this study should,
however, be mentioned. Over time a constant high risk of stroke in patients with
severe stenosis was assumed. Therefore, the long-term benefits of endarterectomy
were overestimated. Moreover, the benefits of operating in symptomatic patients
with 50% stenosis and over, still considered ‘false positives’, was not taken into
account. Thus, the fact that Kent et al. found an acceptable incremental CE ratio for
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the combination strategy can be explained. With relatively optimistic long term
benefits and underestimated benefits for patients with intermediate grade stenosis
that are inadvertently operated a limited risk due to diagnostic work-up becomes
acceptable and a higher specificity more relevant. In this respect our study took
into account essential new information and contributes to further insight.
An interesting finding not often observed was the apparent negative correlation
between costs and QALYs across the strategies. This can be explained by the high
cost incurred and the strong reduction in quality of life after (major) stroke. Incident
strokes are the key events driving the results. The order of diagnostic strategies is
determined by the prevention of immediate and future cerebrovascular events.
Expected costs decrease and QALYs increase as the diagnostic strategies are
optimized in this respect. Such a clear negative correlation is not observed (results
not presented) between the costs and life years. Although strokes for a major part
still drive the costs incurred, the impact on longevity is not as outspoken, and a
scattered non-correlated distribution of costs and effects was observed.
A point of surgical or technical interest that we can not substantiate or reject based
on the available data pertains to the outcome after carotid endarterectomy. If surgeons
were to decide to operate based on a stenosis diagnosed by means of DUS, i.e.,
a flow velocity above some threshold, they would not have detailed anatomic
information available prior to the operation. Although some may argue that this
information has no relevance for the operative approach or outcome, others may
challenge this opinion. Fact is that in the large clinical trials all surgeons had
detailed anatomic information available prior to operation because DSA was routinely
performed in all patients. DUS as a stand-alone test will remain the optimal test
only if the complication rate or effectiveness is not altered without anatomic
information anatomic information, e.g., on the origo or intracranial part of the carotids.
Surgeons uncomfortable operating without anatomic information available prior to
the operation or convinced that they can not operate safely and effectively without
anatomic information may insist on having an MRA image. They can still be confident
that they will improve efficacy and save costs compared to using DSA.
Also, at least a slight benefit for the patients may be expected compared to DUS
alone, albeit at relatively high cost.
As to the reliability of the above findings and the inference made we feel that
although considerable ‘extrapolation‘ occurs while using modeling techniques as
explicated in the methods section, the results obtained are quite robust. The diagnostic
study was performed in a large representative and consecutive sample of symptomatic
patients. Also, the test characteristics were calculated based only on the findings
from the ipsilateral (symptomatic) carotid artery, thus avoiding the overestimation
of specificity that would have resulted from including the asymptomatic carotid
arteries in the analysis.
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Several limitations of our study should be recognized when interpreting the results.
The population included patients pre-screened by means of DUS. The prevalence of
severe stenosis and the test-characteristics estimated may have been biased because
not all symptomatic patients underwent MRA and DSA. This selected verification
may have resulted in an overestimate of the sensitivity of DUS and MRA and an
underestimate of the specificity. However, as this applies equally to DUS (here
DUS as a stringent ‘final’ test is considered) as well as MRA the test characteristics
would very likely have changed proportionally. Accordingly, the order of preference
for the diagnostic strategies in terms of clinical outcomes is not affected. With the
costs of the tests unchanged no change in terms of ordering of cost-effectiveness
ratios is to be expected. Similarly, the combination of DUS and MRA would still be
associated with high additional costs that might well be considered unacceptable.
With regard to strategies including DSA these were dominated as a result of
complications occurring. Adjusting for verification bias would not have altered the
results obtained in this respect. Complications would still occur and if in reality a
smaller proportion of the patients undergoing DSA would be able to benefit from
operation it is likely that the results would be even more extreme. Finally, we feel
that although strictly speaking the test characteristics presented may not be quite
correct they do apply to the domain of interest, i.e., patients pre-selected by means
of a screening DUS. Accordingly, we think that in spite of the fact that the point
estimates of our findings might change a little the interpretation would remain
similar. Also, a recent report by a US group using data from a comparable setting
corroborates our findings adding further to the credibility and robustness of the results
of our study.27
A further limitation may be the fact that we did not take into account unrelated
medical and non-medical costs, e.g., cost and effects related to non-fatal
contra-lateral strokes. We think, however, that it is reasonable to assume that
endarterectomy does not alter the prognosis with regard to contra-lateral strokes or
other long-term cardiovascular outcomes, other than peri-procedural complications
that we did take into account. Also, in an incremental comparison of strategies
such outcomes would have dropped out of the equation anyhow.
Finally, we chose not to perform an extensive sensitivity analysis for the prognostic
model. The results obtained in the prognostic model were used as given input for
the diagnostic model. However, as the underlying estimates used in the prognostic
model are based on large scale multi-center trials we think this is an acceptable
simplification. Taking into account very limited uncertainty with regard to the trial
results would have added substantially to the complexity of modeling, whereas one
could hardly expect a change in the overall results and inference.
A point not related to validity but of potential interest is the currently used threshold
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for operation. The recently published results from NASCET demonstrated limited
benefit for symptomatic patients with 50% to 69% carotid stenosis, particularly men
with TIA or minor stroke, which is reflected in our results. The strategies with an
indication threshold for carotid endarterectomy of 50% stenosis all yielded favourable
CE ratios when compared to similar strategies with a 70% threshold. However, our
sensitivity analyses on the complication rates of endarterectomy indicated that if
peri-procedural stroke rates were to surpass approximately 10%, the high threshold
for surgery would yield more favourable outcomes and should thus be upheld.
This is in accordance with concerns previously expressed by various authors who
emphasized that potential advantages of operating on symptomatic patients may
be cancelled out or even overshadowed by complications of surgery.3,28
Carotid endarterectomy should only be performed in centers able to maintain a
stable and low complication rate. In view of the recently published results from
CAVATAS, a large clinical trial comparing the results of carotid endarterectomy
with angioplasty, showing around 10% major complications, we feel impelled to
stress the fact that the complication rates attained should be monitored and taken
into account when deciding on an optimal diagnostic and treatment strategy.29
A final remark should be made on contrast enhanced MRA (CE-MRA). Around the
time our study commenced time-of-flight MRA was state-of-the-art for vascular
imaging, whereas CE-MRA was not widely used or available. Recently we performed
a small series (N=50) that shows that the images obtained by means of CE-MRA do
not have the drawback of possible flow related artifacts. The latter may at times
result in poor quality images and difficulties in establishing the stenosis grade
precisely. Potentially contrast enhancement could contribute to an even higher
accuracy of MRA, especially with regard to specificity. However, as our present
analysis shows, the gain in accuracy that may be obtained as compared to DUS and
especially as compared to time-of-flight MRA, is likely to result in only marginal
increases in QALY gain. The increase in cost, however, will be substantial thus
resulting in quite unfavourable incremental CE ratios.
In conclusion, DUS as a stand-alone test is the most cost-effective diagnostic test to
select patients for CEA, provided that optimal operative outcomes can be maintained.
Adding MRA to further improve the selection process or to provide additional
anatomical information results in an improved efficacy, however, would still be
associated with relatively high additional costs. DSA has a significant complication
rate and should no longer be routinely applied in the selection process for carotid
endarterectomy.
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Overestimation of carotid artery stenosis by MRA compared to DSA
Abstract
Background and purpose:
Three-dimensional time-of-flight (3D TOF) magnetic resonance angiography (MRA)
is generally considered to overestimate the degree of stenosis in the internal carotid
artery (ICA) in comparison with the reference standard intra-arterial digital subtraction
angiography (DSA). We evaluated whether the degree of stenosis is more accurately
assessed by 3D TOF MRA, if corresponding projections on MRA and DSA are
compared, instead of comparing maximum stenosis at MRA with maximum stenosis
at DSA.
Methods:
From February 1997 to December 1999 we included 186 symptomatic and 17
asymptomatic consecutive patients suspected of having carotid artery stenosis based
on clinical presentation and screening with duplex ultrasound examination.
All patients subsequently underwent DSA and MRA imaging. From each ICA 12
maximum intensity projections (MIP) by 3D TOF MRA and two or three projections
by DSA were obtained. First, we compared the maximum stenosis at MRA with the
maximum stenosis at DSA. Subsequently, we used the stenosis at MRA measured on
the projection corresponding with the DSA projection that showed the maximum
stenosis. For both strategies, the mean differences in stenosis, and sensitivity and
specificity for assessing severe stenosis (70-99%) were calculated and compared.
Results:
MRA and DSA images of 354 ICAs could be compared. Sensitivity and specificity of
MRA using the projection that showed the maximum stenosis were 92.6% (95% CI,
85.3% to 97.0%) and 82.7% (95% CI, 78.1% to 87.3%), respectively. Sensitivity and
specificity using the MRA projection, corresponding with the DSA projection showing
the maximum stenosis, were 88.3% (95% CI, 81.8% to 94.8%) and 89.6% (95% CI,
85.9% to 93.3%), respectively. The mean difference between maximum stenosis at
MRA and DSA was 7.5% (95% CI, 5.2% to 9.9%). The mean difference between
stenosis at MRA and DSA in corresponding projections was 0.4% (95% CI, -2.0% to
2.7%).
Conclusion:
If corresponding MR angiographic and intra-arterial DSA projections are compared,
3D TOF MR angiography does not overestimate carotid stenosis.
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Introduction
Two randomized trials, the North American Symptomatic Carotid Endarterectomy
Trial (NASCET) and the European Carotid Surgery Trial (ECST), both established that
carotid endarterectomy is beneficial to patients with transient or non-disabling
ischemic symptoms associated with severe internal carotid artery (ICA) stenosis
(70-99%).1,2 In these trials the degree of stenosis was assessed with inta-arterial
digital subtraction angiography (DSA), which therefore has become the standard of
reference. DSA is usually performed in two or three projections (lateral,
posteroanterior, and/or oblique). The projection that shows the maximum stenosis is
used to assess the degree of stenosis. However, several studies have demonstrated
that the residual stenotic lumen is almost never circular and that DSA performed in a limited
number of projections does not always reveal the narrowest residual lumen.3-7
Therefore, standard DSA does not always show the maximum stenosis.
Because DSA has a relatively high complication rate, non-invasive techniques such
as three-dimensional time-of-flight (3D TOF) magnetic resonance angiography (MRA)
have been suggested to replace DSA.8-10 However, studies comparing 3D TOF MRA with
DSA have reported that MRA tends to overestimate the degree of stenosis.6,7,11-15
Flow velocity gradients, acceleration, and complex flow patterns, causing intravoxel
dephasing and leading to local signal loss, as well as the used maximum intensity
projection (MIP) algorithm, have been suggested to explain this overestimation.13,16,17
We assumed that the greater number of projection images that are obtained by MRA
could also attribute to the overestimation of stenosis at MRA when compared with
DSA.
In a previous study we compared lumen reduction measurements obtained with
rotational angiography, which allows visualisation of the carotid bifurcation in many
projections, with measurements at conventional DSA in the standard two or three
projections.18 Images provided by rotational angiography and DSA in corresponding
projections showed similar degrees of stenosis. However, using additional projections,
rotational angiography would have identified 16% extra carotid arteries with a severe
ICA stenosis (70-99%) compared to conventional DSA. Since three-dimensional MRA
usually provides 12 or more projections, this phenomenon may also explain (part of)
the overestimation of this technique.
We performed a pilot study comparing the most severe ICA stenosis at twelve
projections on 3D TOF MRA with the most severe stenosis at DSA in the standard
two or three projections (lateral, posteroanterior, and/or oblique). Additionally, we
compared MRA with the most severe stenosis at rotational angiography, providing
16 or 32 circular projections.19 In our small study population, including 32 carotid
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arteries, 3D TOF MRA overestimated the degree of maximum stenosis significantly
by approximately 8% if compared with DSA performed in two or three projections,
whereas this difference was reduced to about 1% if MRA was compared with
rotational angiography.
In the current study we compared 3D TOF MRA with standard DSA in a large cohort.
At first we compared maximum stenosis at MRA in twelve MIP projections with
maximum stenosis at DSA in two or three projections. Subsequently, we compared
stenosis at the MR angiographic projection, corresponding with the DSA projection
showing maximum stenosis, with DSA. In addition, we compared the results.
We studied the effect on the different stenosis categories and on the decision to
perform carotid surgery.
Methods
From February 1997 to December 1999 we included 186 consecutive patients with
symptoms of carotid disease (transient ischemic attack, stroke, or amaurosis fugax)
in the past 6 months suspected of having carotid artery stenosis at duplex
ultrasonography examination. Additional 17 asymptomatic patients were included
who had non-specific symptoms, contralateral ICA occlusion, or symptoms more
than 6 months ago. One hundred and sixty patients were men and 43 women.
The mean age was 65 years (SD, 9; range, 40 to 86 years).
Patients were included if they were suspected of having carotid artery stenosis at
duplex ultrasound examination and scheduled to have DSA because carotid
endarterectomy was considered. After having obtained written informed consent all
patients subsequently underwent MRA examination. MRA was usually performed
within one week, and always within one month of the DSA. The study was approved
by the hospital ethics committee.
DSA was performed with a Philips Integris V3000 angiographic unit (Philips Medical
Systems, Best, The Netherlands) by selective positioning of an intra-arterial catheter
in both common carotid arteries using the Seldinger technique. Two or three
projections, -lateral, posteroanterior, and/or ipsilateral oblique-, were acquired from
each carotid bifurcation.
MRA was performed on a 1.5-T MR imaging system (Gyroscan ACS-NT; Philips
Medical Systems) using the three dimensional time-of-flight technique.
Postprocessing subvolumes were generated to isolate each carotid artery and to
create 12 MIP images that were radially projected at 15° increments (rotation about
the long axis of the body).
DSA and MRA examinations were evaluated by a senior radiologist on different
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occasions, with at least a 1-week interval. The observer was blinded for the other
test results and patient data. ICA stenosis was measured on printed hard-copies
according to the NASCET method (Stenosis=[1-(Minimal Residual Lumen/Distal ICA
Lumen Diameter)]x100%)1. At DSA the percentage ICA stenosis was measured on
all available projections showing the ICA without overlapping vessels.
The maximum stenosis was selected and its projection was noted. From the twelve
MIP images on MRA, the percentage ICA stenosis was assessed on three projections,
coinciding with the vast majority of the DSA projections used (lateral, posteroanterior,
and 45° ipsilateral oblique). If another projection clearly revealed a more severe
stenosis, the percentage stenosis was also assessed on this projection. If an occlusion
was suspected at 3D TOF MIP images, 2D TOF images were subsequently evaluated,
as this technique is more sensitive to slow flow. If flow was not detectable in the
expected course of the distal ICA, the vessel was regarded as occluded. If flow was
detected, the vessel was considered to be patent and subtotally stenosed.
MRA images of ICAs showing a flow void artefact were considered as severely
stenosed (70-99%).20 For calculations of the mean differences in ICA stenosis, these
vessels as well as vessels showing a subtotal stenosis or occlusion, and normal non-
stenosed vessels were excluded from analysis, since the exact percentage stenosis
according to the NASCET method in these vessels can not be assessed.
The maximum stenosis at DSA was compared with the maximum stenosis that was
initially assessed at MRA evaluation. Subsequently, the maximum stenosis at DSA
was compared with the stenosis at MRA in a corresponding projection. The degree
of stenosis was categorised as 0%-29%, 30%-49%, 50%-69%, 70%-99%, or occlusion.
Sensitivity and specificity with 95% confidence intervals (CI) were calculated for
assessing severe ICA stenosis (70-99%) at MRA (ie, selecting patients for carotid
endarterectomy), using DSA as the reference standard. The McNemar test was used
to compare the test-characteristics of MRA for selecting patients with a 70-99% ICA
stenosis, in case maximum stenosis at MRA was used, with the test-characteristics
of MRA, in case the stenosis at MRA was obtained on a projection corresponding
with the DSA projection that showed maximum stenosis. The mean differences in
ICA stenosis between maximum stenosis at MRA and maximum stenosis at DSA,
and between stenosis at MRA, using the projection corresponding with the DSA
projection showing maximum stenosis, and maximum stenosis at DSA were calculated
with 95% CI. This analysis was performed for the total group of arteries and for the
arteries divided into subgroups according to the different stenosis categories.
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Results
Of the 203 included patients, three angiograms could not be retrieved and 13 MRA
examinations were not performed due to claustrophobia (n=8) or lack of MRI
availability (n=5). One patient refused further co-operation after inclusion in the
study. Of the remaining 372 carotid arteries of 186 patients, 5 ICAs could not be
assessed at DSA, because of too many overlapping vessels (n=3) or complications
during the procedure (n=2). Thirteen ICAs could not be assessed at MRA, caused by
movement of the patient during the test.
For the remaining 354 ICAs (Table 1 and 2), sensitivity and specificity of MRA for
assessing an ICA stenosis of 70% or more using maximum stenosis at MRA were
92.6% (95% CI, 85.3% to 97.0%) and 82.7% (95% CI, 78.1% to 87.3%), respectively.
Sensitivity and specificity of MRA for assessing an ICA stenosis of 70% or more
using the MR angiographic projection, corresponding with the DSA projection that
showed the maximum stenosis, were 88.3% (95% CI, 81.8% to 94.8%) and 89.6%
(95% CI, 85.9% to 93.3%), respectively. Test-characteristics of MRA for selecting
patients with severe ICA stenosis (70-99%) were significantly different (p<0.01) when
MR angiographic projections were used that corresponded with DSA projections
that showed maximum stenosis, instead of using the maximum stenosis at MRA.
DSA
MRA 0%-29% 30%-49% 50%-69% 70%-99% 100% Total
0%-29% 66 8 1 75
30%-49% 13 10 3 26
50%-69% 3 15 23 4 45
70%-99% 1 5 38 87 1 132
100% 3 73 76
Total 83 38 65 94 74 354
Table 1. Categorised lumen reduction measurements of maximum ICA stenosis at MRA in 12
MIP projections versus those at DSA in two or three projections.
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DSA
MRA 0%-29% 30%-49% 50%-69% 70%-99% 100% Total
0%-29% 74 11 2 87
30%-49% 9 12 11 1 33
50%-69% 12 29 7 48
70%-99% 3 23 83 1 110
100% 3 73 76
Total 83 38 65 94 74 354
Table 2. Categorised lumen reduction measurements of ICA stenosis at MRA, using the
projection corresponding with the DSA projection showing maximum stenosis, versus those
at DSA.
Of the 354 ICAs for which MRA and DSA could be compared, 35 were normal, 59
showed a signal void at MRA, 6 showed a subtotal stenosis, and 77 were occluded
at either DSA or MRA. For the remaining 177 ICAs, the mean difference in ICA
stenosis between maximum stenosis at MRA and maximum stenosis at DSA was
7.5% (95% CI, 5.2% to 9.9%) (Table 3). The mean difference between stenosis at
MRA, using the projection corresponding with the DSA projection showing
maximum stenosis, and maximum stenosis at DSA was 0.4% (95% CI, -2.0% to
2.7%). In addition, the difference between the two calculated mean differences
was 7.2% (95% CI, 5.6% to 8.7%). The results for the different subgroups of stenosis
are listed in Table 3. In all subgroups the mean difference of MRA is lower if the
corresponding projections with DSA are used. The effect of overestimation, however,
is most apparent in the milder stenosis categories.
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Figures 1 and 2 show the results of measurements of maximum ICA stenosis at MRA
versus maximum stenosis at DSA and the results of measurements of stenosis at
MRA, using the projection corresponding with the DSA projection showing maxi-
mum stenosis. In Figure 1, a substantial number of measurements are above the line
of equality, indicating MRA overestimated the stenosis as compared with DSA.
Figure 2, however, shows that measurements of ICA stenosis at MRA and DSA in a
corresponding projection are more similar. Figures 3 and 4 illustrate how MR
angiographic images in other projections than in the two or three projections obtained
at DSA may reveal a more severe ICA stenosis.
Table 3. Mean differences in ICA stenosis between maximum stenosis at MRA and maxi-
mum stenosis at DSA (A), and between stenosis at MRA, using the projection corresponding
with the DSA projection showing maximum stenosis, and maximum stenosis at DSA (B).
Additionally, the difference between the two calculated mean differences (A-B).
Category of
stenosis
according to
DSA
A: Mean difference of
maximum stenosis
MRA(12 projections) and
DSA (95% CI)
B: Mean difference of
corresponding
projections MRA and
DSA (95% CI)
Difference (A-B)
(95% CI)
N (number of
carotids)*
0-29% 14.8% (10.0% to 19.3%) 6.1% (2.2% to 10.1%) 8.7% (5.0% to 12.3%) 47
30-49% 7.1% (0.6% to 13.7%) -0.8% (-7.7% to 6.1%) 7.9% (4.0% to 11.9%) 37
50-69% 7.8% (4.2% to 11.3%) 0.0% (-4.1% to 4.0%) 7.8% (5.2% to 10.5%) 59
70-99% -2.5% (-5.6% to 0.6%) -5.6% (-9.2% to 2.0%) 3.1% (1.2% to 5.0%) 34
Total group 7.5% (5.2% to 9.9%) 0.4% (-2.0% to 2.7%) 7.2% (5.6% to 8.7%) 177
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F igure 2. Scatter plots show
measurements of ICA stenosis obtained
at MRA, using the projection
corresponding with the DSA projection
showing maximum stenosis, versus
maximum stenosis obtained at DSA.
Normal vessels and carotid arteries
showing a signal void, subtotal stenosis
or occlusion are excluded. Compared
with Figure 1, more measurements are
at or around the line of equality,
indicating that measurements of ICA
stenosis at MRA and DSA in a
corresponding projection showed more
agreement.
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Figure 1. Scatter plots show
measurements of maximum ICA stenosis
obtained at MRA versus maximum
stenosis obtained at DSA. Normal
vessels and carotid arteries showing a
signal void, subtotal stenosis or occlusion
are excluded. A substantial number of
measurements are above the line of
equality, indicating that measuring
maximum stenosis at MRA results in
more severe estimates of ICA stenoses
than measuring maximum stenosis at
DSA.
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Figure 3. From the A. posteroanterior, B. 45° ipsilateral oblique, and C. lateral digital subtraction
angiographic projections of the carotid bifurcation, the posteroanterior projection reveals the
maximum ICA stenosis (a moderate 50%-69% stenosis, arrow in A.). The corresponding three MR
angiographic MIP images (D., E., and F.) show the same configuration of the ICA as DSA. An
additional MR angiographic MIP image (G.), however, depicts the ICA as a 70%-99% stenosis
(arrow).
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Figure 4. Digital subtraction angiographic projections (A. posteroanterior and B. 45° ipsilateral
oblique) reveal a moderately stenosed ICA (arrow in B.), which was estimated similarly at the
corresponding MR angiographic MIP images (C. and D.). However, according to another MR
angiographic projection (E. contralateral oblique), which reveals a severe stenosis (arrow), the ICA
should be operated.
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Discussion
3D TOF MR angiography overestimated carotid stenosis when the most severe stenosis
at MR angiography from the 12 MIP images available was used and compared with
the most severe stenosis at intra-arterial DSA, performed in two or three projections.
This finding was consistent with results of other studies. 6,7,11-15 In our study, MRA
overestimated ICA stenosis with one category or more in 22% and underestimated
stenosis in 5% of the arteries. Additionally, the mean difference in stenosis (7,5%)
was statistically significant. However, using MRA projections that corresponded
with DSA projections did not systematically overestimate ICA stenosis. Using this
approach MRA overestimated ICA stenosis in only 14% and underestimated ICA
stenosis in 9% of the cases and no significant mean difference in percentage
stenosis between MRA and DSA was found. This indicates that corresponding
projections should be used for the most accurate comparison of a new imaging
technique with the reference standard DSA, which results from the fact that residual
stenotic lumen is almost never circular.
We realise, however, that 3D TOF MRA in our study still misclassified 23% of the
carotid stenoses. From these incorrectly classified stenoses 42% had clinical
relevance i.e. would result in a different decision with view on carotid
endarterectomy.
In the categories with milder degree of stenosis there was a reasonable amount of
over and underestimation (i.e. misclassification as compared to the reference test).
Other factors than using different projections of the vessel must account for this
effect. First, it is important to realise that in a diagnostic study a new test by definition
never exactly agrees with the reference test, and that a certain variation in the
observed test results will always occur.21 Secondly, the stenosis can be missclassified,
because measurements on MIP images of MRA can be complicated by signal loss
due to intravoxel dephasing in the stenotic area. Signal loss might depend on the
MRA technique used (3D TOF is less susceptible to flow related artefacts than 2D
TOF because of the smaller voxel size), gradient moments and echo times of the
imaging protocol, and the complexity of the blood flow in and beyond the steno-
sis.16 Complexity of blood flow depends on the velocity proximal to the stenosis, on
the severity of stenosis, and on the configuration of the stenosis (ie, ulceration and
irregular plaque cause irregular flow patterns and, hence, signal loss).22 Therefore,
whether or to what extent intrastenotic signal loss affects lumen reduction
measurements will vary for each specific carotid stenosis.
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In table 3 the mean differences in stenosis measurements between MRA, for both
described methods, and DSA, are lined out for the different categories of stenosis.
In all subgroups the mean difference is lower if the corresponding projections at
DSA are used. Remarkably, in the 70-99% group the mean difference of MRA with
DSA is negative also if the maximum stenosis of 12 projections is assessed. However,
this subgroup is relatively small and the CIs of the mean differences of the two
methods overlap and the differences are therefore not significant. Nevertheless,
a possible explanation might be that the residual lumen of the stenosis in this subgroup
is very small in absolute sense. With stenosis measurement according to NASCET,
the diameter of the residual lumen is divided by the diameter of the normal lumen
distal to the stenosis. Therefore, a possible effect of overestimation decreases as the
percentage of stenosis increases.
NASCET recently concluded that patients with a symptomatic carotid stenosis of
70% or more benefit substantially from carotid endarterectomy for at least 5 years.1
The beneficial effect of carotid endarterectomy is far less and only marginal
significant for patients with a 50% to 69% stenosis. In fact, only men, patients with
recent stroke, and patients with hemispheric symptoms really benefit, provided that
the risk of stroke or death due to the operation does not exceed 2%. Because of the
apparent beneficial effect for all symptomatic patients with a 70% or more carotid
stenosis, we choose a threshold of 70% for selecting patients eligible for carotid
endarterectomy. Using this threshold, sensitivity and specificity of 3D TOF MR
angiography were about 90%. If we had chosen a threshold of 50%, sensitivity and
specificity of 3D TOF MR angiography would have been better, although one has to
take into account that the initial duplex screening may affect these data. Sensitivity
and specificity would have been 95.6% and 87.7%, respectively, if maximum stenosis
at MR angiography was compared with maximum stenosis at IA-DSA, and 89.3%
and 91.8%, respectively, if corresponding projections of MR angiography and
IA-DSA were compared.
Contrast-enhanced MRA (CE-MRA) becomes more frequently used for imaging of
the carotid arteries.23,24 This technique provides additional morphological information
about the origin of the carotid arteries and intra-cranial vessels, and the effect of
flow related artifacts occurring with the time-of-flight technique is diminished.
The use of intravenous contrast results in a stronger signal with better background
suppression, and less signal saturation. However, suppression of signal from the
jugular vein overlapping the carotid bifurcation is one of the drawbacks of this
technique. Suppression can be achieved by scanning the carotid arteries within
10 seconds after enhancement (before venous return). Until recently, however,
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the poor resolution of three-dimensional methods, even on high-gradient hardware,
did not yet allow accurate measurements of carotid stenosis.25
More recent studies have used other methods for venous signal suppression, allowing
longer scanning time and, hence, better spatial resolution and seem very
promising.15,24,26,27  To date, however, only a few studies, with relatively small study
populations, have been published reporting the results of contrast-enhanced MRA
validated against DSA.
In conclusion, we believe that 3D TOF MRA is a thoroughly validated technique in
selecting patients for carotid endarterectomy. MRA overestimated carotid stenosis
when the most severe stenosis at MR angiography from the 12 MIP images available
was used and compared with the most severe stenosis at DSA, performed in two or
three projections. However, using MRA projections that corresponded with DSA
projections did not systematically overestimate ICA stenosis. When new techniques,
e.g. gadolinium-enhanced three-dimensional MR angiography, are validated, using
conventional DSA as standard of reference, we recommend the use of identical
projections of the ICA. Otherwise, the greater number of projections of the ICA on
MRA will most certainly cause overestimation of carotid stenosis. With regard to
NASCET findings the diagnosis of the most severe stenosis at the standard three
projections remains the essential clinical criterion for the decision on carotid
endarterectomy.
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TOF-MRA: Does a flow void represent severe (70-99%) stenosis?
Abstract
Background and Purpose
The time-of-flight technique (TOF) is a commonly used magnetic resonance
angiography (MRA) technique to visualise the carotid arteries. However, the
appearance of flow void artefacts is one of the drawbacks of this modality.
Most diagnostic studies on MRA use the assumption that a flow void represents
severe stenosis (70-99%), based on technical explanations. Correct estimation of
the degree of stenosis is of crucial importance with regard to the decision on carotid
endarterectomy. Therefore, we validated flow voids in a clinical study, using digital
subtraction angiography (DSA) as the reference test.
Methods
390 consecutive patients suspected of having carotid artery stenosis at Duplex
ultrasound (DUS) examination were included in this study over the period
1997-2000. All patients subsequently underwent 3D-TOF MRA and conventional
DSA. We determined the frequency of flow void artefacts in this population on
3D-TOF MRA imaging and compared them with stenosis measurements on DSA.
Results
We recorded 107 flow voids (16%) on the 3D TOF MRA examinations of 662 carotid
arteries. DSA images for comparison were available in 102 of these 107 cases.
The median percentage of stenosis in this subgroup of flow voids on MRA was 80%
when compared with stenosis measurement on DSA according to the NASCET
criteria. The stenoses ranged from 36% to 100% (occlusion). Three flow voids (2,9%)
fell into the 0-49% range of stenosis, 11 (10,8%) in the 50-69% range, 86 (84,3%) in
the 70-99% range and 2 (2,0%) represented an occlusion (100%). The positive
predictive value of a flow void artefact for the presence of severe stenosis (70-99%)
was 84,3% (95%CI, 77,3%-91,4%).
Conclusion
In this clinical study flow void artefacts represent severe stenosis in the vast majority
of the arteries. According to our data, the assumption that a flow void on 3D TOF
MRA represents severe stenosis is justified.
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Introduction
Traditionally Digital subtraction angiography (DSA) has been widely used to visualise the
carotid arteries. On the basis of randomised trials it became the gold standard to select patients
for carotid endarterectomy.1-4 DSA, however, has a relatively high risk of morbidity and
mortality.5,6 Non-invasive tests such as Duplex ultrasound (DUS) and Magnetic resonance
angiography (MRA) are therefore increasingly used in the diagnosis of carotid artery stenosis
avoiding the risks associated with DSA.7-11 The most commonly used MRA technique is
time-of-flight (TOF) MRA. Although new techniques such as contrast-enhanced MRA are
promising for the future, this technique is not yet commonly used and mostly restricted to
specialised centres.12,13
One of the main problems in imaging carotid arteries with TOF MRA is the possibility of flow
void artefacts (signal loss near to the stenosis).14 This phenomenon is believed to occur
particularly in stenosed lumen of arteries due to turbulence of the blood flow. In imaging
carotid arteries the frequency of flow voids might be 10 to 20%. Most diagnostic studies on
MRA therefore use the assumption that a flow void represents severe stenosis (70-99%).15-18
This assumption is mostly based on technical explanations rather than clinical studies.
One publication studied the appearance of flow void artefacts using DSA as the reference
standard in a series of 50 patients, and concluded a very good accuracy of concordant DUS
findings and the presence of a void on MRA in recognising severe stenosis.19
In our opinion correct interpretation and estimation of the degree of stenosis of a flow void
artefact is of crucial importance with view on the decision on carotid endarterectomy in
clinical practice. In the present paper we studied the frequency and diagnostic meaning of
flow voids on patient data, as part of a larger study in which MRA was compared with the
reference standard DSA.
Time-of-flight MRA
The time-of-flight (TOF) MRA method is a gradient echo technique in which contrast is obtained
by the inflow of fresh, unsaturated blood through an image section with (pre)saturated static
tissue. This makes visualisation of the lumen of an artery possible. Both two-dimensional (2D)
and three-dimensional (3D) techniques are applied. 2D TOF MRA uses very thin slices as
scan volumes. The signal of blood is very high, making the technique very sensitive to distinguish
slow flow from occlusions. The scanned volume in 3D TOF MRA is larger. 3D techniques has
a higher spatial resolution, a greater signal-to-noise-ratio and is less sensitive for voids then 2D
TOF MRA due to smaller voxels and shorter echo time. With 3D TOF MRA the degree of
stenosis of the carotid artery can be measured according to the NASCET1 using post processing
maximum intensity projections of the bifurcation of the carotid artery.
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Flow voids
In carotid artery imaging the frequency of flow voids on TOF MRA might be 10 to
20%. Flow voids are considered to be caused by blood flow disturbances near to a
stenosis. Based on technical explanations, however, exact estimation of the degree
of stenosis remains impossible. When reading TOF MRA scans, one should realise
that this technique does not provide purely morphological images, but relies on the
signal created by flowing blood. For this reason, direct comparison of DSA and TOF
MRA is not at all straightforward. A problem commonly observed with 2D and 3D
TOF MRA is local reduction of signal or even total signal loss due to spin dephasing
caused by the presence of complex flow patterns distal to high-grade stenoses.20
It has been shown that the severity of such dephasing artefacts depends on the
gradient wave forms of the imaging sequence used21 and on many parameters related
to the hemodynamics of the stenosis, like its geometry, the average blood flow
velocity, the Reynolds number, the turbulence intensity and the turbulent fluctuation
velocity.22 Because of the complex nature of the post-stenotic signal appearance
(PSA) on TOF MR angiograms, and especially the hemodynamic aspects involved,
accurate grading of stenoses on MR images from a technical point of view remains
very difficult, even with knowledge of the present flow rate. Still, flow-induced
signal loss, also called flow void, distal to a stenosis in the internal carotid artery on
TOF angiograms is assumed to reflect the presence of a severe stenosis (70-99%).
In this study we will test if classification as severe stenosis (70-99%) is appropriate
when a flow void is observed with TOF MRA examination on patient data.
Because of the clinical relevance of selecting the right patients for carotid
endarterectomy, we studied the incidence of this phenomenon and validated the
appearance of flow void in relation to stenosis measurements on DSA.
Methods
Study population
From January 1997 to November 2000, 390 consecutive patients suspected of having
carotid artery stenosis at DUS examination and scheduled to have DSA prior to
possible carotid endarterectomy were included in a prospective diagnostic study.
Subsequently, all patients underwent MRA examination. Ninety-one percent of the
patients had experienced symptoms of carotid artery disease (transient ischemic
attack, minor disabling ischemic stroke, or amaurosis fugax) in the prior six months,
nine percent was asymptomatic. We excluded patients who had contraindications
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for MRA such as metal implants not suitable for MR or claustrophobia. All patients
gave their written informed consent. Our study was approved by the medical ethical
committees of the participating hospitals. The baseline characteristics of the patients
are listed in table 1. The accuracies of MRA and DUS in comparison with DSA from
the total study population will be published elsewhere.23
Diagnostic tests
All patients underwent DUS, DSA and MRA within a period of one month.
The degree of stenosis on DUS was determined based on the peak systolic velocity
(PSV) in the proximal part of the internal carotid artery, which is the most accurate
estimator of the degree of stenosis for DUS.24 We used a PSV of 270 cm/sec as
threshold representing 70% stenosis and 210 cm/sec representing 50% stenosis
according to DSA.25
DSA was performed by selective positioning of an intra-arterial catheter in both
common carotid arteries using the Seldinger technique. Two or three projections,
lateral, posteroanterior, and/or ipsilateral oblique, were acquired from each carotid
bifurcation.
MRA was performed on a 1.5-T MR imaging system using the three dimensional
time-of-flight technique. A 3D spoiled gradient echo acquisition was applied using
the following parameters: repetition time (TR) 30 ms, echo time (TE) 6.9 ms, excitation
angle 15 degrees, field of view 96x120, acquisition matrix 147x256, 50 slices with
a thickness 1.0 mm, reconstructed to 100 slices of 0.5 mm. The number of signal
averages was 3 and a quadrature head coil was used as receiving coil. The scan
duration was about 9 minutes. Postprocessing subvolumes were generated to isolate
each carotid artery and to create 12 MIP images that were radially projected at 15°
increments (rotation about the long axis of the body).
The DSA and MRA test results were read by one observer in each hospital (AFJW;
AvdL). The observer was blinded for clinical information and for the results of the
other tests. The DSA and MRA results were read independently with a period of at
least one month between the readings. The observers examined DSA and MRA on
printed hard copies. The stenoses were measured on both DSA and MRA according
to the NASCET criteria.1 Flow voids on MRA were defined as complete loss of signal
in the internal carotid artery for a minimal length of 1 mm on the MIP images of
both 2D and 3D TOF MRA images. Per definition signal had to reoccur distal from
the flow void signal in the ICA. To assess the inter-observer variability in recognising
a flow void artefact a second observer read the tests of a sub-series of 200 consecutive
patients.
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In addition, the quality of all DSA examinations was assessed by using a score
ranging from 1 to 3 (1: good, 2: moderate, 3: inferior quality). In this score the
overall quality of the examination as well as more detailed items such as
overprojection and applicability to measure the degree of stenosis are incorporated.
Analysis
The frequency of flow void on MRA was calculated in the total study population.
From the flow voids observed on MRA the corresponding estimated stenosis on DSA
and DUS was recorded. Proportions from the voids divided over the different categories
of stenosis (0-49%, 50-69%, 70-99%, 100%) were calculated. The positive predictive
value of flow void for presence of severe stenosis using DSA as the gold standard
was estimated. Inter-observer variability in recognising a flow void was assessed by
estimating the kappa. Additionally, we studied whether the degree of stenosis on
DSA (in case of a flow void on MRA) was related to the quality of the test, using the
Chi-squared test.
Table 1.  Baseline characteristics study population.
Characteristics (N=390)
Age (years) {range}
Male/Female (%)
Symptoms* (%)
Amaurosis fugax / retinal
Transient ischemic attack
Stroke
Asymptomatic
Hypertension (%)
Diabetes (%)
Cardiac history (%)
Angina
Myocardial infarction
Heart failure
Bypass-surgery or PTCA
Peripheral arterial disease (%)
Claudication
Surgery or PTA
Smoking (%)
Smoker
Ex-smoker
67 {39 88}
76/24
20
38
33
9
48
14
18
16
6
11
15
8
49
34
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Results
In total 390 consecutive patients were included in the study (76% male). The mean
age of our study population was 67 years (range 39-88 years). Ninety-one percent of
the patients had experienced neurological symptoms in the 6 months prior to the
date of inclusion (Table 1).
TOF MRA examinations of sufficient quality were available of 662 carotid arteries. During the
readings of the examinations of these 662 carotid arteries 107 flow voids (16,2%) were
recorded. Stenosis measurements of the DSA examinations were available in 102 of the 107
arteries. The median percentage of stenosis from the flow voids was 80% with a range of  36%
to 100% (occlusion), when they were compared with stenosis measurements on DSA according
to the NASCET criteria. In comparison with DSA 3 flow voids (2,9%) fell in the 0-49% range
of stenosis, 11 (10,8%) in the 50-69% range, 86 (84,3%) in the 70-99% range and 2 (2,0%)
represented an occlusion (Table 2). In the group of severe stenosis (70-99%) nine cases of
slow flow or string sign were recorded according to DSA and were graded as 99% stenosis.
Stenosis according to DSA N flow voids (%)
0-49% 3 (2,9%)
50-69% 11 (10,8%)
70-99%* 86 (84,3%)
Occlusion (100%) 2 (2,0%)
Total 102 (100%)
Table 2. Degree of stenosis according to DSA from 102 flow voids occurring with
time-of-flight MRA.
Stenosis categories DSA
0-49% 50-69% 70-99% 100% Total
0-49%
Stenosis 50-69% 1 2 3
Categories 70-99% 3 10 79 1 93
DUS 100% 1 1 2
Total 3 11 82 2 98
Table 3. Categorised degree of stenosis on DUS and DSA. All 98 carotid arteries in this table
were recognised as flow voids on MRA.
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The positive predictive value of a flow void artefact for presence of severe stenosis
(70-99%) according to DSA was 84,3% (95%CI, 77,3%-91,4%). The kappa statistic
for the inter-observer variability in recognising a flow void was 0,81
(95%CI, 0,76-0,83).
MRA, DUS and DSA results were all three assessed in 98 of the total number of 107
carotid arteries in which MRA showed a flow void artefact. Table 3 illustrates the
concordant and discordant findings by tabulating DUS versus DSA results. DSA did
not conclude severe stenosis (70-99%) in 16 cases were MRA showed a flow void.
In 10 out of the 14 arteries in which DSA showed <70% stenosis, DUS did show
severe stenosis.
There was a trend between the better quality of DSA and the larger proportion of the
carotids in which the angiogram showed severe stenosis. This proportion was 87,5%
in the group of DSA examinations with good quality and declined to 78,3% in the
group with moderate quality to 71,4% in the group with inferior quality (Table 4).
However, this trend was not significant (Chi-squared test: p=0,15).
No of arteries (%)
Quality score DSA <70% or 100% 70-99%* Total
1: good 9 (12,5%) 63 (87,5%) 72 (100%)
2: moderate 5 (21,7%) 18 (78,3%) 23 (100%)
3: inferior 2 (28,6%) 5 (71,4%) 7 (100%)
Table 4. Proportion of DSA examinations showing severe stenosis (70-99%) and not showing
severe stenosis (<70% or 100%) versus the quality score of the tests. All 102 carotid arteries in
this table were recognised as flow voids on MRA.
* Non-significant linear-by-linear association (Chi-squared: p=0,15).
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Figure 2.  Example: male, age 64 (TIA of the right hemisphere). MRA (left) showed a
short flow void artefact distal to a visible irregular plaque in the internal carotid artery
(arrow). On all other available projections on 3D TOF MRA, (12 in total, except for two
directions with overprojection making the internal carotid artery invisible), there was an
interruption of the blood flow signal. The flow void was confirmed on the transversal 2D
TOF MRA images. DSA (right) also showed the irregular stenosis with an ulcerated
plaque in the internal carotid artery. The measurement of the most severe stenosis on
DSA, however, resulted in a moderate stenosis (50-69%) (arrow).
Figure 1.  Example: male, age 70 (minor stroke of the right hemisphere). MRA (left)
showed a long flow void artefact (arrow). DSA (right) clearly showed a severe stenosis
(70-99%) in the internal carotid artery (arrow).
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Discussion
In visualising carotid arteries with 3D TOF MRA we found a frequency of 16% of
flow void artefacts near by the stensoses. Flow voids are often considered to represent
severe stenosis (70-99%), based on technical explanations. In the present clinical
study the positive predictive value of a flow void artefact for presence of severe
stenosis (70-99%) was 84,3% according to the reference standard DSA. The median
percentage of stenosis was 80%, with a range of 36% to 100%. In this clinical study
flow void artefacts represent severe stenosis in the vast majority of the arteries.
According to randomised trials patients with a symptomatic severe stenosis of the
ICA (70-99%) benefit from carotid endarterectomy. Patients with a 50-69% stenosis
have smaller benefit and it is expected that in the near future more determinants
will be published selecting the right subpopulation for surgical treatment.3
Diagnosis of 70-99% stenosis therefore remains crucial in the work-up of patients
with carotid artery disease. DSA traditionally has been the gold standard for estimating
the degree of stenosis of the ICA on basis of the trials. Because DSA has a relative
high risk on complications, non-invasive techniques such as MRA and DUS are
increasingly used. A commonly applied technique is time-of-flight (TOF) MRA.
If DSA were to be abandoned patients have to be selected for surgery on basis of
MRA, most likely after screening with DUS. Occurrence of flow related artefacts is
one of the drawbacks of the time-of-flight technique. However, correct interpretation
is very important with view on the decision on carotid endarterectomy. In the current
study patients suspected of having carotid artery stenosis at DUS were examined
with TOF MRA. Flow void artefacts appeared in 16% of the observed arteries, which
we think is relatively often. Although the population was selected, because patients
were initially screened with DUS before undergoing DSA and MRA examination,
this population exactly reflects the domain in which MRA would be performed if
DSA were to be abandoned.
New developments such as contrast-enhanced MRA (CE-MRA) might decrease the
problem of flow related artefacts in the near future.12,13,17 The frequency of voids is
expected to be lower but the problem of artefacts has not yet disappeared with the
introduction of this technique. Furthermore, the exact causes of artefacts in
CE-MRA remain unknown. CE-MRA has not yet been validated in very large series
using DSA as the reference test. Moreover, this technique is not yet generally
accepted and its use is still mostly restricted to specialised centres.
The assumption that a flow void on TOF MRA represents a severe stenosis is confirmed
by our data. In 84% of the voids that appeared in our study the reference standard
DSA concluded 70-99% stenosis. The voids ranged from 36% to 100%. In 14% of the
cases (14 arteries) stenosis was < 70%. Important is the fact, however, that 11 of
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these 14 arteries fell into the 50-69% category. The remaining 3 represented a
0-49% stenosis according to DSA. The quality of the DSA examinations in the group,
in which this test did not show severe stenosis, seemed lower than in the group in
which it did show severe stenosis. Although this difference was not statistically
significant, we feel this strengthens our conclusion that a flow void can be considered
as severe stenosis in the work up of patient prior to possible carotid endarterectomy.
In all 16 cases in which a flow void on MRA did not represent a severe stenosis
(70-99%) on DSA, the DUS and DSA examinations were retrospectively re-evaluated
by a senior radiologist (WPThM) and a senior vascular surgeon (BCE).
In 7 examinations this non-blinded re-evaluation showed inferior quality of DSA,
making adequate measurement of the stenosis difficult. In these cases they could
not decide on carotid endarterectomy on basis of the presented DSA only. In 4 cases
the stenosis or atherosclerotic disease seemed worse then the stenosis measurement
according to the protocol indicated, and together with the DUS results they tended
to advise on carotid endarterectomy. In 5 cases there was no comment on DSA or
DUS examination. The total number of cases of flow void in the presented series
with the gold standard available is relatively large. In most cases of flow void on
MRA where DSA had not concluded severe stenosis, the quality of the reference test
was inferior and/or the stenosis seemed worse than only the measurement of
stenosis percentage could indicate. The conclusion that the DSA examinations of
the group showing <70% had shortcomings in establishing the severity of the disease,
was supported by the fact that DUS did show severe stenosis (PSV>270 cm/sec) in
10 out of the 14 arteries.
In conclusion, flow voids, appearing in 16% of the carotid arteries with TOF MRA
imaging, in our opinion need to be assessed with care with view on the clinical
decision on carotid endarterectomy. In our patient series flow void artefacts represent
severe stenosis in the vast majority of the arteries. We feel that this finding is
strengthened by the fact that the quality of DSA tended to be worse and the fact
DUS showed severe stenosis in most of the arteries in the group in which DSA did
show <70% stenosis. In general we think the assumption that a flow void on 3D TOF
MRA represents severe stenosis is justified.
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Abstract
Background and Purpose:
On the basis of large randomised trials conventional intra-arterial digital subtraction
angiography (DSA) is the standard of reference in the decision on performing carotid
endarterectomy. Contrast-enhanced MR angiography (CE-MRA), a promising
non-invasive imaging test, is increasingly used in the assessment of carotid artery
stenosis. The technique yields possible advantages such as diminishment of flow
related artefacts and allows visualisation of a long tract of the carotid artery from
origin to intra-cranial siphon. In the present paper we introduce a 3D CE-MRA
technique visualising the carotid artery from the origin to the intra-cranial siphon.
The aim of this study was to assess the accuracy and reproducibility of CE-MRA in
diagnosing carotid artery stenosis compared with 3D time-of-flight MRA and the
reference standard DSA.
Methods:
In a prospective diagnostic study we performed CE-MRA, 3D TOF MRA, and DSA on
51 consecutive patients suspected of having carotid artery stenosis at duplex
ultrasound examination. Stenoses were measured by two independent observers
using the NASCET method. The observers were blinded for clinical information and
other test results.
Results:
CE-MRA, 3D TOF MRA, and DSA yielded comparable test results. The Pearson’s
correlation coefficients were 0.94 (p<0.01) for CE-MRA compared with DSA, 0.92
(p<0.01) for 3D TOF MRA compared with DSA, and 0.93 (p<0.01) for CE-MRA
compared with 3D TOF MRA. The kappa statistics reflecting the inter-observer
variability were 0.81 for CE-MRA, 0.79 for 3D TOF MRA, and 0.78 for DSA.
Stenosis measurements of the first observer on CE-MRA, with inclusion of the carotid
arteries on the symptomatic side only, compared with the reference standard DSA,
yielded a sensitivity of 90% (95%CI, 68%-99%) and a specificity of 77% (95%CI,
55%-92%) in the diagnosis of severe stenosis (70-99%). 3D TOF MRA yielded a
sensitivity of 86% (95%CI, 67%-97%) and a specificity of 73% (95%CI, 50%-89%)
compared with DSA.
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Conclusion:
CE-MRA showed promising preliminary results. The diagnostic accuracy of CE-MRA
in the diagnosis of severe stenosis (70-99%) is similar to 3D TOF MRA.
CE-MRA allows visualisation of a long tract of the carotid artery, from origin to
siphon. Furthermore, compared to 3D TOF MRA, CE-MRA diminishes occurrence of
flow related artefacts.
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Introduction
Two large randomised clinical trials, The North American Symptomatic Carotid
Endarterectomy Trial (NASCET) and the European Carotid Surgery Trial (ECST), have
proven the benefit of carotid endarterectomy in patients with severe symptomatic
carotid artery stenosis (70-99%).1,2 Recent publications have shown that subgroups
of patients with a 50-69% stenosis may also expect a small benefit from carotid
endarterectomy.3,4 The diagnosis of severe stenosis (70-99%), however, remains crucial
for the majority of patients.
The degree of stenosis in the endarterectomy trials was established by conventional
intra-arterial digital subtraction angiography (DSA), which has become the standard
of reference for selecting patients for carotid surgery. DSA in patients with
atherosclerosis, however, has a relatively high risk of morbidity and mortality.
In the literature a risk of 4% of transient ischemic attack (TIA) or minor stroke and
1% of major stroke, and even a small risk of death (<1%) have been reported.5,6
Even patients without apparent neurological complications after DSA have been
shown to develop minor asymptomatic infarctions due to micro-embolisms.7
Therefore, non- or minimal-invasive techniques such as 3D time-of-flight (TOF) MR
angiography (MRA) and contrast-enhanced magnetic resonance angiography
(CE-MRA) are increasingly used supplementary to duplex ultrasound in the dia-
gnosis of carotid artery stenosis. In the last decade 3D TOF MRA was the most
commonly applied MR technique. Several studies have proven good diagnostic
performance in the selection of patients for carotid surgery.8-13 More recently,
CE-MRA has been introduced, enabling visualisation of a longer tract of the carotid
artery compared to 3D TOF MRA, including origin and intra-cranial parts.14-16
Furthermore, CE-MRA diminishes the possibility of flow related artefacts, one of the
drawbacks of the TOF technique. To date, however, only few studies have been
published reporting the results of contrast-enhanced MRA validated against the
reference standard DSA.17 A recently published review concluded that MRA is highly
sensitive and specific in diagnosing severe carotid artery stenosis (70-99%), however,
that included studies were of poor and heterogeneous quality.18 More importantly,
they concluded that further research was essential to assess the diagnostic value of
contrast-enhanced MRA. We recently developed a 3D CE-MRA technique that
visualises the complete tract of the carotid artery from origin to the siphon within 10
seconds before venous return. The high resolution of 0.75 x 0.75 x 1.0 mm should
potentially allow good visualisation of near-occlusions with high flow velocities in
the internal carotid artery and decrease the effect of flow related artefacts.19-21
The aim of this study was to assess the accuracy and reproducibility of CE-MRA
compared with 3D TOF MRA and the reference standard DSA in the diagnosis of
carotid artery stenosis.
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Methods
Study population
From June 1999 to May 2000, 51 consecutive patients were included in this
prospective diagnostic study. All patients were suspected of having carotid artery
stenosis and were screened with duplex ultrasound. If carotid endarterectomy was
considered, patients subsequently underwent CE-MRA, 3D TOF MRA, and DSA
examination within a period of maximum two weeks. Forty-nine patients had
experienced symptoms of carotid artery disease (transient ischemic attack, minor
disabling ischemic stroke, or amaurosis fugax) in the prior six months. The remaining
2 patients were asymptomatic: one was evaluated because of vertigo with a
progressive stenosis on duplex examination, the other because of a stenosis found
on duplex during work-up after endarterectomy of the anonyma. We excluded patients
who had contraindications for MRA such as metal implants not suitable for MR or
claustrophobia. All patients gave their written informed consent. Our study was
approved by the medical ethical committee. The baseline characteristics of the
patients are listed in Table 1.
Diagnostic tests and stenosis measurements
CE-MRA and 3D TOF MRA were performed on a 1.5-T MR imaging system (Gyroscan
ACS-NT; Philips Medical Systems, Best, the Netherlands). For CE-MRA Bolus trak
technology (Philips Medical Systems) was applied to determine the arrival of the
contrast bolus in the carotid artery. This scan-protocol included an optimised centric
profile order and a variable scan matrix. The scan parameters were:
repetition time (TR) = 4.5 ms, echo time (TE) = 1.5 ms, flip angle = 40°, 70 slices,
slice thickness = 0.4 mm, a variable scan matrix (reconstructed matrix 320 x 512)
and a 256 x 140-mm2 rectangular field of view. The contrast material used was a
5-mM solution of gadopentate dimeglumine (Magnevist, Schering). Imaging time
was approximately 44 seconds. The actual resolution was 0.75 x 0.75 x 1.0 mm.
In the TOF protocol first a sagittal scout two-dimensional phase-contrast image with
30 cms-1 velocity encoding and two-dimensional TOF images (30 consecutive
4-mm-thick transverse sections) were acquired for localising the carotid arterial
bifurcation and for planning the 3D TOF acquisition. A carefully planned 3D TOF
MR angiographic acquisition was performed by using a radio-frequency spoiled
gradient-echo sequence with 50 1-mm-thick transverse sections (interpolated to
100 sections), a superior saturation band, 31/6.9 (repetition time ms/echo time ms),
a flip angle of 15°, flow compensation, a field of view of 120 x 80 mm, an imaging
matrix of 256 x 256, and three signals acquired. Imaging time was approximately
9 minutes.
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The TOF MRA protocol was always performed prior to the CE-MRA protocol, to
avoid image disturbances due to remaining contrast. In both 3D TOF MRA and
CE-MRA postprocessing subvolumes were generated to isolate each carotid artery
and to create 12 MIP images that were radially projected at 15° increments (rotation
about the long axis of the body).
Intra-arterial DSA was performed with a Philips Integris V3000 angiographic unit
(Philips Medical Systems) with an image intensifier matrix of 1024 x 1024. By using
the Seldinger technique, the tip of a 5-F catheter was guided from the common
femoral artery to the ascending aorta and positioned in the right and, subsequently,
in the left common carotid artery. Two or three projections (lateral, posteroanterior,
and/or ipsilateral oblique) were acquired from each carotid bifurcation. For each
projection 6 ml of contrast agent (Ultravist [300 mg of iodine per ml]; Schering) was
injected at a flow rate of 3 ml/s.
The 3D TOF MRA, CE-MRA, and DSA results were read independently by two observers
(O.E.E. and P.J.N.), with a period of at least one month between the readings.
The tests were read with the observers blinded for clinical information and for the
results of the other tests. ICA stenosis was measured on printed hard-copies according
to the NASCET method (Stenosis=[1-(Minimal Residual Lumen/Distal ICA Lumen
Diameter)] x 100%) by using a mechanical calliper with a digital display. On DSA
the percentage ICA stenosis was measured on all available projections showing the
ICA without overlapping vessels. From the twelve MR angiographic MIP images,
the percentage ICA stenosis was assessed on three projections, coinciding with the
vast majority of the IA-DSA projections used (lateral, posteroanterior, and 45°
ipsilateral oblique). Flow void artefacts on 3D TOF MRA were defined as 85% stenosis.
Analysis
First, the data was analysed including two arteries per patient, i.e. both carotid
arteries, to compare all stensosis measurements of CE-MRA and 3D TOF MRA with
the reference standard DSA and of CE-MRA with 3D TOF MRA. Scatterplots were
constructed and Pearson’s correlation coefficients were calculated, according to
the measurements of the first observer. Subsequently, for all three imaging tests the
inter-observer variability was calculated using kappa statistics with categorised
stenosis measurements: 0-29%, 30-49%,  50-69%, 70-99% and 100% (occlusion).
In the second part of the analyses, to assess the accuracy of CE-MRA and 3D TOF
MRA compared with the reference test DSA in the diagnosis of severe stenosis
(70-99%), with regard to the decision making on carotid endarterectomy, we included
only one carotid artery per patient, i.e. the symptomatic side, in the analyses. In the
two asymptomatic patients that side was included on which carotid endarterectomy
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was considered. We calculated the sensitivity and specificity with 95% confidence
intervals (CIs) for the diagnosis of severe (70-99%) stenosis of CE-MRA and of 3D
TOF MRA compared to DSA for both observers.
Finally, we recorded the frequency of flow related artefacts on 3D TOF MRA, and of
possible tandem lesions on DSA and CE-MRA; i.e.stenosis >50% in the origin, in the
siphon, or else in the tract of the carotid artery.
Results
Fifty-one consecutive symptomatic patients were included in the study (44 male, 7
female). The mean age of the study population was 64 years (range 39-88 years, SD
9.6). Baseline characteristics are summarised in Table 1. CE-MRA was of
non-diagnostic quality in five patients. These cases were excluded from the
analyses. Reasons for non-diagnostic quality were failure in the timing of contrast
arrival and start of the scan, causing too much venous over-projection of the jugular
vein for an adequate assessment of the degree of stenosis of the internal carotid
artery. The 5 non-diagnostic CE-MRA procedures were performed in the first period
of the study. After the first phase of our study failure in timing no longer occurred.
The test results of the remaining 46 patients (92 arteries) could be included in the
analyses.
Characteristics (N=51)
Age (years {range})
Male/Female (n)
Symptoms (%)*
Amaurosis fugax / retinal
Transient ischemic attack
Stroke
Asymptomatic
Hypertension (%)
Cardiac history (%)
Angina
Myocardial infarction
Bypass-surgery or PTCA
Peripheral arterial disease (%)
Claudication
Surgery or PTA
Smoking (%)
Smoker
Ex-smoker
64 {39 88}
44/7
17
44
35
4
38
18
18
12
8
13
58
18
Table 1.  Baseline characteristics study population.
* 0-6 months prior to inclusion
121
Diagnostic value of contrast-enhanced MRA in carotid artery stenosis
Figure 1. Scatterplots of  the measured percentage of stenosis of all arteries by the first observer
on CE-MRA versus on DSA (A), on 3D TOF MRA versus on DSA (B), and on CE-MRA versus on 3D
TOF MRA (C). The Pearson’s correlation coefficients were 0.94 (p<0.01), 0.92 (p<0.01), and 0.93
(p<0.01) respectively.
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Stenosis measurements on CE-MRA compared with the reference standard DSA,
with inclusion of the carotid arteries of symptomatic side only, yielded a sensitivity
of 90% (95%CI, 68%-95%) and a specificity of 77% (95%CI, 55%-92%) in the
diagnosis of severe stenosis (70-99%) for the first observer (Table 2). For 3D TOF
MRA sensitivity and specificity were 86% (95%CI, 67%-97%) and 73% (95%CI,
50%-89%), respectively. The results of observer 2 were in a similar range and are
listed in Table 2.
On 3D TOF MRA 6 flow voids were recorded, whereas on CE-MRA a flow related
artefact near by the stenosis occurred in only one case. On DSA once we recorded
a stenosis of  >50% in the right common carotid artery in one patient, and once a
stenosis of  >50% in the left siphon in another patient. The diagnosis of both stenoses
could be confirmed on CE-MRA, whereas the limited field of view of 3D TOF MRA
did not allow visualisation of these parts of the carotid artery.
Figures 1 shows the scatterplots of the measured percentage of stenosis of all arteries
by the first observer on CE-MRA versus DSA (Figure 1A), on 3D TOF MRA versus
DSA (figure 1B), and on CE-MRA versus 3D TOF MRA (Figure 1C). The Pearson’s
correlation coefficients were 0.94 (p<0.01), 0.92 (p<0.01), and 0.93 (p<0.01)
respectively. The kappa statistics reflecting the inter-observer variability between
observer 1 and observer 2 were very good and similar for the three tests: 0.81 for
CE-MRA, 0.79 for 3D TOF MRA, and 0.78 for DSA.
Observer 1 Observer 2
Test
Sensitivity
% (95%CI)
Specificity
% (95%CI)
Sensitivity
% (95%CI)
Specificity
% (95%CI)
CE-MRA 90 (68-95) 77 (55-92) 91 (70-99) 76 (52-91)
3D TOF
MRA
86 (67-97) 73 (50-89) 90 (68-99) 77 (51-92)
Table 2. Accuracies of CE-MRA and 3D TOF MRA compared with the reference test DSA in
the diagnosis of severe stenosis (70-99%). Only the carotid arteries of the symptomatic are
included (n=46).
123
Diagnostic value of contrast-enhanced MRA in carotid artery stenosis
Discussion
Although we studied a relatively small study population of consecutive patients,
CE-MRA shows promising preliminary results and appears an accurate test in the
diagnosis of carotid artery stenosis. In our study CE-MRA yielded a sensitivity and
specificity comparable to 3D TOF MRA in recognising severe stenosis (70-99%)
compared to the reference test DSA.
MRA is increasingly used in imaging of carotid artery stenosis. In the last decade
several studies have been published comparing MRA with DSA.8-13 The most
commonly applied technique in these studies was TOF MRA. In the last few years
implementation of CE-MRA has been repeatedly suggested in the diagnosis of carotid
artery stenosis.14-16 CE-MRA of the carotid arteries is a recent development that
could minimise signal loss and motion artefacts. By using an intravenous contrast
bolus this technique allows shortening of T1 and a longer flip angle, generating a
stronger signal with better background suppression and less signal saturation.
Suppression of signal from the jugular vein overlapping the carotid bifurcation,
however, has been one of the main drawbacks. Suppression can be achieved by
scanning the carotid arteries within 10 seconds after enhancement (before venous
return). Until recently, the poor resolution of three-dimensional methods, however,
even on high-gradient hardware, did not allow accurate measurements of carotid
stenosis.19 Nowadays other methods for venous signal suppression, allowing longer
scanning time and, hence, better spatial resolution are available.22-24
To date, however, only few studies have been published comparing CE-MRA with
the reference test DSA in sufficient large populations.17,19-21  In 1998 Slosman et al
introduced a non-breath-hold 3D gadolinium enhanced MRA technique,
but concluded after comparison with 3D TOF MRA and DSA in 50 patients that the
technique could not yet be recommended in the diagnosis of carotid artery
stenosis.19 The main limitation was the difficulty with the timing of contrast arrival,
and consequently the overprojection of the jugular veins, in about 30% of the carotids.
Serfaty et al (2000) found a sensitivity and specificity of  94% and 85% respectively
for 3D CE-MRA in a population of 48 patients. In their study 90% of the tests yielded
good image quality. They concluded, however, that CE-MRA should not be used as
stand alone but only in combination with duplex ultrasound instead of DSA.17
Randoux ea. (2001) compared CE-MRA and DSA in 22 patients and found a sensitivity
and specificity of 93% and 100% respectively.20 Their conclusion was that CE-MRA
could be an adequate substitute for DSA. In their series they found only 2 CE-MRA
less than adequate for diagnosis. Recently Remonda (2002) compared first-pass
CE-MRA with DSA in 120 patients and found agreement between both tests in 93%
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in the detection of severe stenosis (70-99%).21 The quality of CE-MRA images of all
patients was graded as adequate for diagnosis.
We have recently developed a 3D CE-MRA technique that visualises the complete
tract of the carotid artery from origin to the siphon. The technique uses an optimised
centric profile ordering of the k-space, allowing data acquisition during the uptake
of the arterial contrast media, ensuring improved resolution by exploiting the tail of
the contrast signal and longer scanning, improved venous suppression and improved
robustness to errors in timing. The high resolution of  0.75 x 0.75 x 1.0 mm and the
use of optimised profile ordering should potentially allow good visualisation of
near-occlusions with high flow velocities in the internal carotid artery and decrease
the effect of flow related artefacts. As in other studies, the timing of arrival of the
contrast bolus and start of the scan was the most crucial part in the introduction of
this new procedure. With the implementation of a new technique the MR
technologists, however, experience a learning curve. The 5 non-diagnostic CE-MRA
procedures were performed in the first period of the study. After the first phase of our
study failure in timing no longer occurred.
Our reported accuracies in the diagnosis of severe stenosis (70-99%) might seem
relatively low compared with literature. However, one should realise that we included
only the symptomatic arteries (i.e. one carotid per patient) in this part of our analysis,
in contrary the cited studies in literature.17,19-21 Including all arteries yields a higher
specificity, due to the fact that the asymptomatic artery often shows a stenosis far
beyond the cut-off point of 70%, and therefore will be often classified correctly by
both tests in the comparisons. Including stenosis measurements of all arteries
(both asymptomatic and symptomatic sides) in our data (observer 1) would result in
a sensitivity of 90% and a specificity of 89% for CE-MRA. These numbers are in line
with literature, and we can conclude that we found a similar accuracy for CE-MRA.
It is preferable to investigate a larger population. Earlier, however, we performed a
diagnostic study comparing 3D TOF MRA with DSA in 350 patients.25 On basis of
the results of this study we do not perform DSA routinely anymore in all patients in
whom carotid endarterectomy is considered. Therefore, we no longer have the
reference standard to our disposal in a consecutive patient series. This implies an
important limitation in the validation of CE-MRA, and of any new technique in
carotid artery imaging, with regard to the endarterectomy trials.
In our relatively small study-population, we could not find a significant difference
in accuracy between 3D TOF MRA and CE-MRA. However, even if a larger population
was to be investigated, it remains uncertain if possible advantages of CE-MRA over
3D TOF MRA can be reflected in a significantly different accuracy. For example,
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Figure 2. Example of a near-occlusion. A) Early DSA image of a right carotid artery. Distal to the
bifurcation the nearly occluded lumen of the internal carotid artery (ICA) is visible. B) Late DSA
image. More contrast appears in the remaining lumen of the ICA. C) 3D TOF MRA: ICA was
diagnosed as occluded (with scoring blinded for the other test results). Retrospectively, a very low
signal could perhaps have been recognised. D) Remaining lumen visible on CE-MRA near by and
distal to the near-occlusion.
A B
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with CE-MRA the occurrence of flow void artefacts strongly diminishes. Because
flow voids on 3D TOF MRA occur in approximately 15% of the imaged arteries, and
are classified correctly as severe stenosis (70-99%) in 85% of the cases, the number
of patients needed to find a significant difference between the two techniques would
be more that one thousand.26 However, there certainly is a clinical advantage in the
availability of good morphology of severely stenosed arteries provided CE-MRA.
Furthermore, in our study CE-MRA correctly classified all occlusions. Figure 2
represents a case in which 3D TOF MRA yielded a false positive occlusion, whereas
CE-MRA visualised the nearly occluded lumen of  the internal carotid artery similarly
to the images of the reference test DSA. Finally, as DSA, CE-MRA allows visualisation
of a long tract of the carotid artery from origin to siphon (Figure 3). In a preliminary
evaluation, the two additional lesions diagnosed with DSA (one in the carotid origin
and the other in the intra-cranial siphon), could be confirmed with CE-MRA.
The accuracy of CE-MRA in recognising tandem-lesions was not studied properly
Figure 3. Visualisation of origin and intra-cranial part of the carotid arteries on CE-MRA.
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yet. Although the effect of additional morphological information of tandem lesions
on the results of carotid endarterectomy has not yet been entirely studied, it is
certainly often taken into account in the decision on carotid endarterectomy in
individual cases.27
In conclusion, CE-MRA seems a promising new technique in the imaging of carotid
arteries. First results show a similar accuracy to 3D TOF MRA in diagnosing severe
stenosis. Our reported diagnostic accuracy is comparable with recent literature.
Preferably CE-MRA should be compared with DSA in a larger study population.
To date, however, DSA is often not performed routinely anymore in all patients in
whom carotid endarterectomy is considered. Therefore, an exact estimate of the
accuracy of CE-MRA compared with DSA, with regard to the results of the carotid
surgery trials, remains unsolved.
CE-MRA shows possible clinical advantages over 3D TOF MRA. The technique
provides additional morphological information about the origin and intra-cranial
part of the carotid artery.  Flow related artefacts are strongly diminished.
Slow blood flow in nearly occluded lumen still provides recognisable signal.
The distinction between occluded and nearly occluded vessels remains of crucial
importance with regard to the decision to perform carotid endarterectomy.
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Patient preferences for DUS, MRA and DSA in carotid artery imaging
Introduction
Non-invasive tests, such as duplex ultrasound (DUS) and magnetic resonance
angiography (MRA) are increasingly used in the work-up of patients suspected of
having carotid artery stenosis in replacement of, or in addition to digital subtraction
angiography (DSA).1,2 The decision on which test or which combination of tests is
applied is predominantly made on basis of the diagnostic accuracy, possible
complication rate, and cost-effectiveness considerations.3,4 When forming
study-cohorts for diagnostic studies, selection due to absolute contra-indications of
patients for a particular test have to be taken into account. For example,
claustrophobic patients, or patients with other contra-indications such as metal
implants, will not undergo MRA examination. Thus, considering these absolute
contra-indications, the analyses and the results of a diagnostic study should reflect
a setting consistent with daily clinical practice. However, discomfort of particular
modalities that do not necessarily preclude performing the imaging test, and,
subsequently, patients’ possible preference for other imaging tests, are generally
not taken into account in the interpretation of the results of a diagnostic study.
In clinical practice, discomforts such as for example confined space for MR imaging,
hospitalisation for DSA, or the time a patient is confined to bed after DSA, might be
decisive factors for the decision for a particular imaging modality in individual
cases. Two earlier studies showed that patients undergoing imaging for peripheral
arterial disease experienced more discomfort due to DSA than to MRA.5,6 As part of
a diagnostic study, including nearly 400 patients who all underwent DUS, MRA,
and DSA imaging, to asses the diagnostic accuracy of non-invasive testing, patients
received a questionnaire about their experiences with the particular imaging tests.
The aim of this paper is to present patient preferences and test related discomforts
for DUS, MRA, and DSA.
Patients, Methods and Results
From January 1998 to November 2000, a consecutive sub-population of 215 patients,
part of a larger study-cohort, received a questionnaire on their preferences for and
possible discomforts due to DUS, MRA, and DSA. In the study, after initial screening
with DUS, all patients subsequently underwent MRA and DSA examination if carotid
endarterectomy was considered. Patients with contra-indications for MRA such as
claustrophobia or metal implants not suitable for MR were excluded. DUS, MRA
and DSA were performed within a period of maximum four weeks.Unless patients
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were hospitalised for planned carotid surgery, DUS and MRA imaging were performed
on an outpatient basis. For DSA the patients were always hospitalised for at least
one night. Imaging protocols are described in detail elsewhere.7 The patients filled
in the questionnaire at home after all imaging tests were performed and returned
them by mail.
The questionnaire was completed and returned by 134 patients (response rate 63%).
On the question ‘which test is most bothersome?’ 71% (95/134) of the patients
answered DSA, 25% (33/134) MRA, none (0/134) DUS, and 4% (6/134) gave no
answer. On the question ‘which test is least bothersome?’ 84% (113/134) of the
patients answered DUS, 10% (14/134) MRA, 2% (2/134) DSA, and 4% (5/134) gave
no answer. On a continuous scale from 0 (not bothersome at all) to 60
(very bothersome), patients median grade for DUS was 0 (SD 5.2), for MRA 10
(SD 15.5), and for DSA 20 (SD 18.7) (figure 1). The three ratings were all significantly
different from each other (Wilcoxon signed-rank test: p<0.001). Subsequently, patients
were asked to rate possible test related discomforts on the same continuous scale
from 0 to 60. Generally, possible discomforts of DUS were ranked lower than for
MRA and/or DSA. The results of the mean rating of the different variables are listed
in Table 1. Of each variable, the Spearman’s correlation coefficient is listed, indicating
the relation of possible discomforts with the overall rating score of the test.
All relations were significant (p<0.01).
N Mean rating (0-60) ! SD Sp-r
DUS
Endurance 133 2.7 6.5 0.57*
Painful or discomforting sensations 131 1.7 4.2 0.55*
Enclosed feeling 131 2.6 7.8 0.50*
MRA
Endurance 131 9.1 12.0 0.58*
Noise 132 15.2 16.6 0.61*
Enclosed feeling 132 13.3 16.5 0.55*
DSA
Endurance 134 15.2 17.0 0.57*
Warm and/or painful sensations 133 17.3 16.7 0.65*
Hospitalisation 133 12.6 16.6 0.33*
Confined to bed for several hours afterwards 134 23.9 21.1 0.58*
Enclosed feeling 131 9.3 14.8 0.40*
Table 1. Experienced test related discomforts and correlation with the overall rating score of
DUS, MRA and DSA.
SD = standard deviation
†  Number of respondents on particular question
‡  Continuous scale from 0 (not bothersome at all) to 60 (very bothersome)
¶  Spearman’s relation coefficient, indicating correlation with overall rating score of the
particular test.
* Statistically significant (p<0.01).
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Comment
We found a statistically significant order in patients’ preference for the particular
tests in carotid artery imaging. Patients that underwent all three imaging modalities
reported hardly any burden of DUS. DSA was graded more bothersome than MRA.
Variables explaining possible discomforts for each of the three tests were significantly
related to the overall rating scores. Our findings are consistent with two earlier
studies reporting that patients undergoing imaging for peripheral artery disease
experienced more discomfort due to DSA than to MRA.5,6 In the latter (Visser ea.),
DUS was also evaluated, however, was graded more bothersome than MRA.
The main limitation of our study is the fact that patients with claustrophobia as
contra-indication for MRA (3%), were excluded from our diagnostic study. The burden
of MRA, therefore, was underestimated. However, the difference with DSA was
large and we have reason to believe that patients still experience DSA as more
bothersome, even after taking this selection bias into account. Furthermore,
still 25% of the included patients answered that they found MRA the most bothersome
test, i.e. more bothersome than DSA.
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Figure 1. Box and whisker plot for the overall rating score for DUS, MRA and DSA. Patients
(N=134) graded the imaging tests on a continuous scale from 0 (not bothersome at all) to 60 (very
bothersome).
The lower and upper lines of the box correspond with the first and third quartiles. The bold line
corresponds with the median. The vertical line represents less than 1.5 times the interquartile
range from the first and the third quartiles. Outliers (O) are defined as more tan 1.5 times and
extremes (*) are defined as more than 3 times the interquartile range outside the box.
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In DUS and MRA the reported test related discomforts are comparable.
In MRA, particularly the noise was reported to be bothersome. In DSA, as we
expected, the overall rating was related to the warm and painful sensations during
the contrast injections. However, the confinement to bed for several hours after
performing DSA was also reported as bothersome. The latter is recognised by clinicians
as an important factor explaining discomfort. Remarkably, discomfort due to
hospitalisation, showed the lowest correlation coefficient.
In our previous work we concluded, based on diagnostic accuracies of non-invasive
tests and on cost-effectiveness considerations, that DSA should not be performed
routinely anymore in all patients suspected of having carotid artery stenosis.4,7
The current analysis of patient preferences supports this conclusion.
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General discussion
The aim of this thesis was to evaluate whether non-invasive tests could replace
intra-arterial digital subtraction angiography (DSA) in the diagnosis of carotid artery
stenosis. To obtain reliable estimates of the diagnostic accuracy of duplex
ultrasound (DUS), magnetic resonance angiography (MRA), and a combination of
these tests, we performed a diagnostic study with DSA as reference, including nearly
400 patients in the period from 1997 to 2000. Subsequently, we performed a
comprehensive cost-effectiveness analysis.
In the literature very good accuracies of non-invasive tests such as DUS and MRA
have repeatedly been reported. In our systematic review, summarising literature
published between 1994 and 2000 (Chapter 2), we reported a pooled weighted
estimate of the sensitivity and specificity in the diagnosis of severe stenosis
(70-99%) for DUS of 86% and 87% respectively. For MRA the pooled sensitivity was
95%, the specificity 90%. As we concluded in Chapter 3, the accuracies for
non-invasive testing obtained from our own diagnostic study (Table 1) might seem
relatively low compared to the literature. We found the highest diagnostic
performance for a combination strategy of DUS and MRA, which yielded a sensitivity
of 96% and a specificity of 80%. However, the results of this strategy apply only for
a sub-population in which DUS and MRA show agreement (85% of the patients),
implying that in approximately 15% of the patients DSA should still be considered.
Sensitivity and specificity for DUS as sole tests were 88% and 76%, and for MRA
92% and 76%, respectively.
The presented results give rise to two important questions: why did we find a lower
diagnostic performance than previously reported in the literature, and what does
this mean for clinical practice? In our opinion, the accuracies we reported can be
considered valid and realistic for three reasons. First, for a thorough evaluation of a
Sensitivity Specificity Positive predictive
value
Negative predictive
value
% (95%CI) % (95%CI) % (95%CI) % (95%CI)
DUS 87.5 (82.1-92.9) 75.7 (69.3-82.2) 75.4 (68.9-82.0) 87.7 (82.3-93.0)
MRA 92.2 (86.2-96.2) 75.7 (68.2-96.2) 76.3 (69.6-83.0) 92.0 (85.8-96.1)
DUS&MRA 96.3 (90.8-99.0) 80.2 (73.1-87.3) 81.2 (74.5-88.0) 96.0 (90.2-98.9)
Table 1. Diagnostic accuracies of the non-invasive tests DUS, MRA, and the combination
strategy (DUS=MRA) in recognising severe stenosis (70-99%) in the internal carotid artery
(ICA), using DSA as the standard of reference.
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diagnostic test an adequately powered study, using a prospective design and a
consecutive study-population, is mandatory. Such a study is likely to be large and
time-consuming. Recently a review of 132 previous publications of diagnostic
studies on carotid artery imaging published between 1993 and 1998 criticised the
design of the majority of these studies.1 Particularly, the number of patients included
in those studies often was too small to justify the conclusions about the diagnostic
performance. While collecting the data for our meta-analysis (Chapter 2) we could
confirm this finding. We think that including a large consecutive population and
collecting the data prospectively provides realistic results.
Another explanation is that we report on the test results of the carotid artery on the
symptomatic side in the analyses. Since it is the symptomatic artery for which a
decision on performing endarterectomy has to be made, excluding the asymptomatic
side reflects clinical practice. Only few studies in literature have presented their
diagnostic data similarly. Previously published reports generally also included the
asymptomatic carotids of the contralateral side. The majority of the arteries on the
asymptomatic side show a stenosis percentage far below the 70% threshold or no
stenosis at all, making it more likely for the different tests to agree. In this way the
number of true negative results inflates and thus the specificity may be overestimated
in those studies. For example, in our data the specificities increased by 10.7% for
DUS and 14.2% for MRA if the stenosis measurements of all arteries were included.
Finally, it is very important to realise that in a diagnostic study a new test by
definition never exactly agrees with the reference test.2 If measurements of DSA
examinations of the same group of patients were to be repeated by the same observer,
we would still certainly find variability in results. In other words, even a theoretically
perfect test will never yield perfect test results. The aim of a diagnostic study should
not be to achieve the highest possible accuracy. The more relevant question is to
what extent a new test under investigation differs from the reference test and what
implications this has on the outcome of clinical decisions for individual patients.
If we assume that the accuracies we reported are valid and realistic, what do they
mean for clinical practice? In other words, do the results allow replacement of DSA
by non-invasive testing? It is not easy to answer this question unambiguously.
Reporting the false positive and false negative rates only is, in our opinion, not
sufficient to completely understand the consequences of implementing a new test
in clinical practice. Additionally, the results of a cost-effectiveness analysis should
be taken into account to understand the true implications of introducing non-invasive
testing. From the limited published evidence available, the cost-effectiveness of
carotid endarterectomy and of the preoperative investigations remained unclear.3
We found (Chapter 4) that the expected lifetime costs and quality adjusted life
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years (QALYs) were almost equal for DUS and MRA, as well as for the combination
strategy. The traditionally used strategy of DSA implies higher costs and a small loss
of QALYs (Table 2). Although the difference with the non-invasive strategies appears
limited, DSA results in a small but significant number of additional complications
(i.e. strokes or deaths). Compared to the total number of evaluated patients the
number of complications is relatively small. However, the reported loss in QALYs is
substantial if the results are extrapolated to the total patient population. In the three
non-invasive strategies additional costs are incurred because selection for carotid
endarterectomy is assumed to be sub-optimal, i.e. the number of outcome events in
the follow-up increases due to the false-positive and false-negative test results.
The tests themselves, however, are less expensive and do not carry the risk of
complications. In the combination strategy the assumption is made that patients
undergo DSA in case of disagreement, giving a small complication rate as well.
From the societal perspective, based on our models, DUS alone would be the strategy
of choice. From the perspective of an individual patient, however, the differences
between the non-invasive strategies are small, and it could be justifiable to select
the most accurate one. From the clinical point of view it seems attractive to add
MRA to DUS. As said before the combination strategy provides a higher diagnostic
performance and therefore is the most accurate replacement for DSA for an individual
case. In addition, MRA provides more morphological information. Surgery results
might very well improve if additional information about possible tandem lesions is
available, however, this has never been investigated. Furthermore, DUS test results
are operator dependent and not all laboratories will achieve the same level of
diagnostic performance. Finally, we should realize that if DUS would be used as
stand alone, unlike MRA or the combination of DUS and MRA, its test results as
presented in this thesis suffer from verification bias.
Strategy Costs (Euro) QALYs
(Quality Adjusted Life Years)
DUS 28,040 11.30
MRA 28,270 11.30
Combination DUS & MRA 28,540 11.29
DSA 30,360 11.22
Table 2. Cost-effectiveness of the four clinically most relevant test strategies.
Chapter 9
144
Verification bias may exist if the decision to perform the reference standard
procedure depends on the results of the test under investigation.4 In our study, patients
were often screened with DUS in the clinical setting prior to inclusion. Based on
ethical grounds, inclusion in the study depended on the decision of the clinician to
perform DSA if CEA was considered. Accuracy of DUS related to the 70% stenosis
threshold was estimated afterwards among patients selected for DSA. The tabulations
show that all categories of degree of stenosis are present, although the majority has
a moderate or severe stenosis. The sensitivity may be lower, and specificity higher,
after adjustment for this bias.
If subsequently MRA is performed in all patients, however, it is precisely this selected
group of patients, suspected of having ICA stenosis at DUS examination, that
constitutes the right domain to answer our study objective, reflecting the population
for which the decision on surgery has to be made in daily clinical practice. Therefore,
the accuracy of MRA, as described in Chapter 2, is not biased. However, it is
important to realise that if DUS would be performed as sole test in clinical practice,
the calculated sensitivity and specificity are influenced by verification bias and do
not reflect the best estimate.
At the start of our study the time-of-flight technique was the state-of-the-art technique
for MRA for imaging of the carotid arteries. The introduction of contrast-enhanced
MRA (CE-MRA) was an important step in the development of MRA techniques during
our study.5 Imaging techniques and protocols develop continuously. While performing
a study of a diagnostic test over a period of several years, the state-of-the-art imaging
protocol most certainly changes. In diagnostic studies it is tempting to switch to a
novelty and publication of preliminary results of a new technique often is appealing.
However, if new protocols were to be adapted within the period of the study,
the size of the study cohort undergoing one and the same test diminishes, which is
a limitation in the assessment of valid test results. If multiple changes are adapted
successively, even if they are small, a summarised estimate of the accuracy of a
test could become invalid. Development of new techniques should not tempt the
investigators to abandon their initially defined imaging protocol. In our opinion the
only correct solution is to maintain the initial protocol, and eventually to add new
protocols or tests to the standard protocol. This allows an evaluation of the improved
protocol in a sub-population, while maintaining the possibility of a more precise
estimate of the initial technique.
One of the limitations of the 3D TOF technique was the occurrence of flow void
artefacts, particularly in severely stenosed carotids (Chapter 6). We reported a
frequency of 16% of flow void artefacts in imaging carotid arteries with 3D TOF
MRA. CE-MRA shows possible clinical advantages over 3D TOF MRA. The technique
provides additional morphological information about the origin and intra-cranial
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part of the carotid artery.  Flow related artefacts are strongly diminished.
Slow blood flow in nearly occluded lumen still provides recognisable signal.
The distinction between occluded and nearly occluded vessels remains of crucial
importance with regard to the decision to perform carotid endarterectomy. After a
learning period we added CE-MRA to our standard MRA protocol in the last period of
our study instead of replacing it. We were therefore able to assess a preliminary
estimate of  the accuracy of CE-MRA in a subgroup of 40 patients (Chapter 7).
However, we realise that a cohort of this size only allows preliminary results.
Although we certainly experienced advantages of CE-MRA compared with 3D TOF
MRA, such as decrease of flow related artefacts and possibility of visualising the
aortic arch and intra-cranial vessels, the estimates of the sensitivity and specificity
yielded relatively large confidence intervals. Only DUS, 3D TOF MRA, and their
combination could be investigated elaborately in the time-span of our study. Because
we do not perform DSA routinely anymore in all patients in whom carotid
endarterectomy is considered, based of the results of the main study, we will no
longer have the reference standard to our disposal in a consecutive patient series.
This implies an important limitation in the validation of CE-MRA, and of any new
technique in carotid artery imaging, with regard to the endarterectomy trials.
Other techniques that were not investigated in this thesis may also play a more
important role in the near future. The use of computer tomographic angiography
(CTA), for example, could increase.6 We chose not to investigate this technique in a
large cohort, because of its limitations compared with MRA, such as problems in
assessing the exact degree of stenosis due to plaque calcifications.
New developments, however, such as the use of multi-detector CT scanners, might
improve this technique. Limitations in validation of this technique as with CE-MRA,
due to absence of the reference test in a consecutive population, will remain.
It is difficult to predict the future role of DUS. In the future more patient related
characteristics, for example infarct size or location, or presence of collateral blood
flow, could play an additional role, besides the assessment of the degree of stenosis
of the carotid artery, in the decision to perform carotid surgery. Consequently, it is
conceivable that MR protocols further expand and that symptomatic patients will
directly undergo an even more extensive program including MR imaging of the
brain and MR angiography of the cerebral circulation. Furthermore, recent
publications have shown that subgroups of patients with a 50-69% stenosis may also
expect a small benefit from carotid endarterectomy.7 Although the diagnosis of
severe stenosis (70-99%) will remain crucial for the majority of patients, we expect
that in the future more patients with a moderate (50-69%) stenosis will be operated.
The question will be whether it will still be useful to perform preceding DUS
examination, if additional imaging would be requested for a larger part of the patient
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population. On the other hand, DUS is an inexpensive and widely available test for
initial screening in patients suspected of having carotid artery stenosis. In addition,
patients prefer DUS examination to other tests and they experience little discomfort
(Chapter 8).
A final point of interest is that the decision on surgery, based on the results of the
carotid endarterectomy trials, is mainly made on basis of the degree of stenosis.
Moreover, the cut-off points for stenosis, obtained from the trials, are strictly defined.
Unfortunately, this precludes a meaningful analysis of the percentage of stenosis as
a continuous variable. Theoretically, the percentage of stenosis could be included
in a model as a risk factor, together with the other patient characteristics, that
nowadays become increasingly important in the decision on carotid surgery and
should be taken into account. Furthermore, in such a model the time-span between
the test and the symptoms could also be included, and by doing so the strict distinction
between asymptomatic and symptomatic patients could possible be abandoned.
To date, a patient is considered symptomatic if neurological symptoms were
experienced strictly within six months prior to the evaluation. The effect of carotid
surgery on asymptomatic patients according to this definition remains unclear, but
ongoing trials will present their results on this topic in the near future.
In clinical practice, based on the results of this study, we no longer perform
DSA routinely in symptomatic patients suspected of having a carotid artery stenosis
after screening with DUS. Particularly with knowledge of the results of the
cost-effectiveness analysis, and with regard to the limitations of a diagnostic study,
the presented results, in our opinion, yield enough evidence to decide not to perform
DSA routinely anymore in all patients. To date, after initial screening with DUS,
we always perform MRA in our non-invasive strategy. In our opinion patients should
now only undergo DSA in those cases where considerable doubt persists about the
indication for carotid endarterectomy after DUS and MRA examination, for example
in case of clear disagreement between these two tests, or when additional
morphological information about origin of the common carotid artery or about
intra-cranial vessels is necessary to make the right decision on performing
endarterectomy. In the majority of patients, however, DSA can safely be replaced
by the combination of DUS and MRA.
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The aim of this thesis was to determine if digital subtraction angiography (DSA)
could be replaced by non-invasive testing. Chapter 1 gives a general introduction,
illustrating the background of this objective. Carotid endarterectomy was shown to
be beneficial in symptomatic patients with a severe stenosis (70-99%) of the internal
carotid artery (ICA) in two large randomised trials. Increasing degree of stenosis
yielded increasing benefit from surgery, making precise estimation of the degree of
stenosis very important. In the trials the degree of stenosis was assessed with DSA,
which consequently has become the standard of reference in the selection of patients
for carotid endarterectomy. DSA, however, has a relatively high risk of morbidity
and mortality, which decreases the potential overall benefit of endarterectomy.
To date, non-invasive tests, such as duplex ultrasound (DUS) and magnetic resonance
angiography (MRA), are increasingly used in the diagnosis of carotid artery stenosis.
These tests do not carry the potential risk of complications. However, with regard to
the results of the carotid surgery trials, it remains very important that the correct
group of patients is selected by new test strategies. In a diagnostic study and a
cost-effectiveness analysis we investigated the consequences of implementation of
non-invasive testing for individual patients and from a societal perspective.
In Chapter 2 the published data in the literature from 1994 to 2001 on the diagnostic
value of DUS and MRA in the diagnosis of carotid artery stenosis is systematically
reviewed. Publications were only included in this meta-analysis if DSA was used as
the reference test in the presented study. For the diagnosis of severe stenosis
(70-99%), MRA had a pooled sensitivity of 95% and a pooled specificity of 90%.
For DUS these numbers were 86% and 87%, respectively. A multivariable summary
ROC analysis demonstrated that the type of MR scanner and the type of DUS
scanner predicted the diagnostic performance. For DUS this phenomenon is known,
whereas for MRA this finding has not been described before. Furthermore, for DUS
the presence of verification bias predicted the diagnostic performance.
Verification bias may exist if the decision to perform the reference test depends on
the results of the test under investigation. The results suggest that MRA has a better
discriminatory power compared with DUS in diagnosing 70-99% stenosis and is a
sensitive and specific test compared to DSA in the evaluation of carotid artery
stenosis.
In Chapter 3 the diagnostic study we performed is described. From January 1997 to
November 2000, 350 consecutive symptomatic patients suspected of having carotid
artery stenosis were included. After initial screening with DUS, the patients underwent
both MRA and DSA examination. All patients in this study had experienced symptoms
of carotid artery disease (transient ischemic attack, minor disabling ischemic stroke,
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or amaurosis fugax) in the six months prior to inclusion. Both DUS and MRA seemed
accurate diagnostic tests to detect carotid artery stenosis. In combining test results,
agreement in diagnosing severe stenosis (70-99%) between DUS and MRA
(84% of the patients) yielded a high sensitivity and specificity. Both DUS and MRA
had the tendency to overestimate stenosis compared with the standard of reference
DSA. Our reported accuracies of DUS and MRA might seem relatively low compared
with other studies. However, we feel that our prospective design and inclusion of a
relatively large study population added to valid and unbiased estimates.
Another explanation is the fact that we only included the test results of the carotid
artery on the symptomatic side in the analyses, yielding lower accuracies. In literature
often test results of both carotid arteries are included in the analyses.
However, since it is the symptomatic artery for which a decision on performing
endarterectomy needs to be made, excluding the asymptomatic side reflects clinical
practice. In clinical practice, based on the results of the diagnostic study, we no
longer perform DSA routinely in symptomatic patients suspected of having a carotid
artery stenosis after screening with DUS.
To be able to understand the consequences of implementation of non-invasive imaging
strategies from a societal perspective, a valid estimate of the diagnostic value is
not sufficient. Additionally to the diagnostic study, a cost-effectiveness analysis
was performed, which is presented in Chapter 4. First, an all including calculation
on the costs of the diagnostic tests and carotid endarterectomy was carried out.
Additional data on long-term costs, survival, and quality of life related to stroke
were retrieved from the published literature. Secondly, the long term outcomes
required for the cost-effectiveness analysis were assessed by means of a Markov
model. Finally, a comprehensive analysis was performed using a decision model,
in which all the different combinations of the diagnostic tests could be compared.
We concluded that, from a societal perspective, DUS without additional imaging is
the optimal diagnostic strategy to select patients for carotid endarterectomy in terms
of cost-effectiveness. The results of DUS, however, could be influenced by
verification bias. A combination strategy of DUS and MRA to select patients for
carotid endarterectomy yields a slight benefit in terms of clinical outcome, however,
at relatively high additional costs. DSA was more expensive and less effective than
all evaluated non-invasive strategies.
In Chapter 5 a possible explanation for the overestimation of MRA compared to DSA
was investigated. Three-dimensional time-of-flight (3D TOF) MRA is generally
considered to overestimate the degree of stenosis in the ICA in comparison with the
reference standard DSA. Several mostly technical explanations have been described
in literature. Often, the shape of the stenosed lumen of the artery, however, is not
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circular. DSA, the reference test based on the carotid surgery trials, is according to
their protocol performed in two or three projections (lateral, posteroanterior, and/or
oblique). In MR imaging of the carotid artery, however, often 12 directions of the
vessels are reconstructed and available for the assessment of the stenosis. We found
that if corresponding MR angiographic and intra-arterial DSA projections are
compared, instead of comparing maximum stenosis at MRA on 12 projections with
maximum stenosis at DSA on the standard three projections, 3D TOF MR angiography
did not overestimate carotid stenosis. The effect of overestimation decreased when
the degree of stenosis increased.
The time-of-flight MRA technique (TOF) was commonly used to visualise the carotid
arteries at the start of our study. As described in Chapter 6, the appearance of flow
void artefacts, especially in severely stenosed arteries, is one of the drawbacks of
this modality. Most diagnostic studies on MRA use the assumption that a flow void
represents severe stenosis (70-99%), based on technical explanations. In the patient
data we validated the occurrence of this kind of artefact. We found a frequency of
16% of flow void artefacts in visualising carotid arteries with 3D TOF MRA.
The positive predictive value of a flow void artefact for presence of severe stenosis
(70-99%) was 84,3% according to the reference standard DSA. The median
percentage of stenosis was 80%, with a range of 36% to 100%. In this clinical study
flow void artefacts represented severe stenosis in the vast majority of the arteries.
For a valid throughout evaluation of a new imaging technique an adequately powered
study is mandatory. However, such a study is likely to be large, expensive and
time-consuming, precluding application of the newest imaging protocols.
Recently, however, we also introduced CE-MRA supplemental to the time-of-flight
protocol, allowing us to estimate its accuracy in a subgroup of patients and preliminary
findings are presented in Chapter 7. CE-MRA seems a promising new technique in
the imaging of carotid arteries. First results show a similar accuracy to 3D TOF MRA
in diagnosing severe stenosis. CE-MRA shows possible clinical advantages over 3D
TOF MRA. The technique provides additional morphological information about the
origin and intra-cranial part of the carotid artery.  Flow related artefacts are strongly
diminished. Slow blood flow in nearly occluded lumen still provides recognisable
signal. The distinction between occluded and nearly occluded vessels remains of
crucial importance with regard to the decision to perform carotid endarterectomy.
Preferably, CE-MRA should be compared with DSA in a larger study population.
To date, however, DSA is often not performed routinely anymore in all patients in
whom carotid endarterectomy is considered. Therefore, an exact estimate of the
accuracy of CE-MRA compared with DSA, with regard to the results of the carotid
surgery trials, remains unsolved.
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Finally, in Chapter 8, we investigated patients’ preferences for DUS, MRA, and
DSA. As part of the diagnostic study, patients received a questionnaire about their
experiences with the particular imaging tests. Patients that underwent all three
imaging modalities reported hardly any burden of DUS. DSA was graded more
bothersome than MRA. Variables explaining possible discomforts for each of the
three tests were significantly related to the overall rating scores. In DUS and MRA
the reported test related discomforts are comparable. In MRA, particularly the noise
was reported to be bothersome. In DSA, as we expected, the overall rating was
related to the warm and painful sensations during the contrast injections.
However, the confinement to bed for several hours after performing DSA was also
reported as bothersome. The latter is recognised by clinicians as an important factor
explaining discomfort. Remarkably, discomfort due to the hospitalisation with DSA,
showed the lowest correlation coefficient.
In Chapter 9 the methodological limitations of a diagnostic study are discussed,
as for example the consequences of inclusions of  the carotids of the symptomatic
side in the analysis only, or the effect of verification bias on DUS results.
The expected further developments in carotid artery imaging are discussed, as well
as the fact that other patient characteristics than the degree of stenosis only might
play a more important role in the future in the decision on carotid endarterectomy.
In clinical practice, based on the results of this study, we no longer perform DSA
routinely in symptomatic patients suspected of having a carotid artery stenosis after
screening with DUS. Particularly with knowledge of the results of the
cost-effectiveness analysis, and with regard to the limitations of a diagnostic study,
the presented results, in our opinion, yield enough evidence to replace DSA by the
combination of DUS and MRA as standard evaluation. In our opinion patients should
now only undergo DSA in those cases where considerable doubt persists about the
indication for carotid endarterectomy after DUS and MRA examination, for example
in case of clear disagreement between these two tests, or when additional
morphological information about origin of the common carotid artery or about
intra-cranial vessels is necessary to make the right decision on performing
endarterectomy. In conclusion, in the majority of patients, DSA can safely be replaced
by the combination of DUS and MRA.
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Nederlanse samenvatting
Hoofdstuk 1 geeft een introductie van de achtergrond bij de vraagstelling van dit
proefschrift. In het verleden is in twee grote gerandomiseerde onderzoeken
aangetoond dat een operatie van de halsslagader (arteria carotis interna) waarbij de
atherosclerotische plak wordt verwijderd nuttig is bij patiënten met een
vernauwing (stenose) van meer dan zeventig procent. Tevens dienen de patiënten
neurologische symptomen gehad te hebben passend bij de stenose. Van patiënten
met een carotis stenose die daarvan geen symptomen hebben ondervonden is nog
niet goed bekend of ze baat hebben bij een operatie. Dit wordt momenteel nog
bestudeerd. Als zo’n carotis desobstructie operatie plaatsvindt bij een patiënt met
een stenose van meer dan zeventig procent is in de jaren daarna zijn risico op het
krijgen van een beroerte verminderd. Digitale subtractie angiografie (DSA) is de
gouden standaard of referentie test voor het diagnosticeren van zo’n stenose. Bij dit
onderzoek wordt er een katheter via een kleine snee in de lies via de lichaams-
slagader naar de halsslagader opgevoerd en er wordt contrast vloeistof ingespoten.
Echter, omdat dit een invasief onderzoek is, waarbij noodgedwongen met de
katheter in de halsslagader wordt gemanipuleerd, geeft het zelf een geringe kans
op het krijgen van neurologische complicaties. Al langer werd duplex geluids-on-
derzoek (DUS) gebruikt voor een eerste screening op de aanwezigheid van een
carotis stenose. Intussen werd het ook mogelijk om met een MRI scanner een MR
angiografie (MRA) te verrichten. Deze beide testen zijn niet invasief en hebben
daarom niet zoals DSA het risico op complicaties. Het doel van dit proefschrift was
om aan de hand van de resultaten van een diagnostische studie met daaraan gekop-
peld een kosteneffectiviteit studie te bepalen of DSA vervangen kon worden door
DUS, MRA of een combinatie van deze testen.
In Hoofdstuk 2 wordt de reeds bestaande literatuur over dit onderwerp uit de
periode van 1994 tot 2001 samengevat. In een meta-analyse werden alle artikelen
bestudeerd met een studiepopulatie van meer dan 15 patiënten waarin MRA of DUS
werden vergeleken met de referentie test DSA. Zodoende konden de gemiddelde
diagnostische waarden voor de diagnose van de carotis stenose van de niet invasieve
testen worden geschat. Voor DUS werden een gepoolde sensitiviteit van 86% en
een gepoolde specificiteit van 87% gevonden. Een sensitiviteit van 86% betekent
dat DUS van de 100 ernstige vernauwingen er 86 opspoort. Van de 100 slagaders
die niet ernstig vernauwd zijn wijst DUS er 87 als zodanig aan (specificiteit).
Voor MRA waren deze waarden respectievelijk 95% en 90%. Deze getallen geven
aan dat beide testen geschikt lijken te zijn voor de diagnose van een ernstige
carotis stenose (70-99%). In een aanvullende analyse werd aangetoond dat voor
DUS de resultaten uit de literatuur mogelijk beïnvloed zijn door verificatie bias.
Verificatie bias speelt in diagnostische studies een rol als alleen patiënten met een
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positieve testuitslag voor aanvullende diagnostiek in aanmerking komen. Dit is een
bekend probleem als DUS met de invasieve angiografie wordt vergeleken, omdat
men patiënten met een kleine kans op een ernstige afwijking niet wil blootstellen
aan een invasieve test. De diagnostische waarden in de verschillende studies
werden zowel bij DUS als bij MRA ook veroorzaakt door het type apparaat
waarmee het onderzoek was uitgevoerd. Voor DUS was dit een bekend fenomeen,
maar voor MRA is deze bevinding in de literatuur nooit eerder gerapporteerd.
Hoofdstuk 3 beschrijft de hoofdstudie van dit proefschrift. In de periode van 1997
tot en met 2000 werden 350 opeenvolgende patiënten geïncludeerd die op basis
van een screenend DUS onderzoek verdacht waren voor het hebben van een carotis
stenose. Alle patiënten hadden in de zes maanden voorafgaand aan de inclusie in
de studie neurologische symptomen ondervonden welke kunnen passen bij een
stenose in de arteria carotis. De patiënten ondergingen na de DUS ook een MRA en
een DSA onderzoek van de carotis. Zowel DUS als MRA bleken na berekening van
de resultaten over deze hele groep adequate testen voor het diagnosticeren van een
carotis stenose in vergelijking met de referentie test DSA. DUS en MRA bleken met
name erg betrouwbaar wanneer ze hetzelfde testresultaat lieten zien.
Echter, wanneer op die manier naar de resultaten wordt gekeken, blijft er een kleine
groep patiënten over (ca. 15%) waarbij DUS en MRA niet hetzelfde testresultaat
laten zien. In die gevallen dient alsnog een DSA overwogen te worden.
De gevonden sensitiviteit en specificiteit van de niet invasieve testen lagen in
onze studie wat lager dan de gemiddelde waarden uit de literatuur. Dit is te
verklaren doordat we een relatief grote en prospectieve studie uitvoerden, maar
met name ook door het feit dat we in plaats van alle beschikbare vaten
(twee carotiden per patiënt) alleen de symptomatische vaten waarbij een
desobstructie-operatie werd overwogen includeerden in onze analyses. In studies
waarbij beide carotiden in de analyses worden meegenomen wordt met name de
specificiteit overschat, omdat er dan veel vaten zonder een stenose zijn waardoor
de overeenstemming tussen de technieken hoger is.
In de diagnostische studie komen we tot de eindconclusie dat DSA in de
meerderheid van de patiënten die verdacht worden van het hebben van een carotis
stenose, en bij wie een operatie wordt overwogen, niet meer als routine onderzoek
dient te worden uitgevoerd. DSA dient alleen te worden verricht bij speciale
indicaties, bijvoorbeeld bij duidelijke discrepantie tussen DUS en MRA resultaten,
of in individuele gevallen waarbij nog andere delen van de vaten bekeken moeten
worden om de beslissing te kunnen nemen.
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In Hoofdstuk 4 wordt de kosteneffectiviteit berekend van het eventueel invoeren
van niet invasieve testen. Met het niet uitvoeren van DSA wordt geld bespaard en
het aantal complicaties ten gevolge van de diagnostiek vermindert.
Vergeleken met de referentie test DSA zal met DUS en/of MRA echter een iets
andere patiënten groep voor operatie worden geselecteerd. Dit komt omdat nieuwe
testen als gevolg van een toevallige variatie nooit precies hetzelfde meten als de
referentie test. Dientengevolge zullen de percentages complicaties na afloop van
de operatie ook iets anders liggen. In een besliskundig model werden de conse-
quenties van die verschillen doorgerekend voor het hele verdere leven van alle
patiënten. Hierbij werden alle mogelijke kosten meegenomen, zoals de kosten van
de diagnostische onderzoeken, van een opname in het ziekenhuis en van het
benodigde personeel, maar ook alle kosten in het verdere verloop zoals bijvoor-
beeld revalidatiekosten na een complicatie of opname in een verpleegtehuis in het
geval van een ernstige beroerte. Berekend over de hele populatie zullen niet
invasieve testen gemiddeld een iets betere levensverwachting geven en zullen
tevens iets goedkoper zullen zijn dan DSA, zelfs met de aanname dat met DSA
precies de goede patiënten worden geselecteerd. Volgens het model zou het uit-
voeren van alleen DUS (zonder MRA) nog het meest gunstig zijn, echter, de
resultaten van DUS zijn waarschijnlijk weer beïnvloed door verificatie bias.
Omdat wij niet goed weten hoe groot de invloed hiervan is kunnen we de exacte
diagnostische waarde niet berekenen.
In de analyses bleek dat MRA de stenosegraad enigszins overschat in vergelijking
met DSA. In Hoofdstuk 5 werd onderzocht of dit verschijnsel te verklaren was
doordat bij MRA gebruik wordt gemaakt van meer projectierichtingen van het te
onderzoeken vat dan bij DSA. Bij routine DSA onderzoek van de carotiden wordt in
drie richtingen naar het vat gekeken, terwijl bij MRA de beschikking is over 12
verschillende projectie richtingen. Inderdaad bleek dat MRA de stenosegraad niet
meer overschat wanneer niet alle twaalf, maar alleen de drie richtingen die met
DSA overeenkomen werden gebruikt. De overschatting was ernstiger naarmate het
vat een minder ernstige stenose vertoonde. Bij de evaluatie van een nieuwe
techniek moet rekening worden gehouden met het feit dat het aantal
projectierichtingen kan verschillen van de referentie test.
De gangbare techniek voor MRA, bij aanvang van onze studie, was de
time-of-flight (TOF) techniek. Dit is een MR techniek waarmee stromend bloed
afgebeeld kan worden. Op die manier wordt de omvang van een bloedvat, en dus
ook eventuele stenosen, in beeld gebracht. Hoofdstuk 6 beschrijft echter een van
de beperkingen. De techniek is erg gevoelig voor wervelingen van het bloed, en
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omdat die juist bij een stenose vaak optreden, kunnen in de gereconstrueerde
beelden artefacten ontstaan. Dat wil zeggen dat ter hoogte van de stenose in plaats
van het lumen een zwart defect in het beeld ontstaat (flow void artefact). Op basis
van de bovengenoemde technische verklaring, en op basis van ervaringen in de
praktijk, werd in de literatuur algemeen aangenomen dat bij de aanwezigheid van
een flow void artefact er sprake moest zijn van een ernstige stenose (70-99%).
In onze studie hadden we de kans om alle opgetreden flow voids te vergelijken met
de precieze afbeelding op de DSA. In de MRA onderzoeken van onze patiënten-
groep kwam in 16% van de in beeld gebrachte vaten een flow void voor.
Hoewel de stenosegraad volgens DSA kon variëren van 37% tot 100% (occlusie),
bleek de aanname dat een flow void een ernstige stenose representeert in het
merendeel van de gevallen gerechtvaardigd (85%) in de klinische praktijk.
Een diagnostische studie neemt noodgedwongen een aantal jaren in beslag. Dit is
onvermijdelijk voor het verzamelen van de gegevens van een patiëntengroep die
groot genoeg is om een precieze schatting te kunnen maken van de diagnostische
waarde van de te onderzoeken test, in ons geval DUS en met name MRA. Het is
echter zeer waarschijnlijk dat in zo’n relatief lange periode de techniek
verandert. Bij aanvang van onze studie was TOF MRA ‘state-of-the-art’ MR techniek
in het afbeelden van bloedvaten. Gedurende onze studie kwam contrast-enhanced
MRA (CE-MRA) steeds meer in opkomst, een techniek die in andere delen van het
lichaam al langer werd toegepast. Hierbij wordt een kleine hoeveelheid
intraveneus contrast toegediend. In tegenstelling tot bij DSA is er geen risico op
complicaties bekend. Na een leerperiode hebben we in het laatste deel van onze
studie in een serie van iets meer dan vijftig patiënten deze techniek toegevoegd
aan het studie protocol. Zodoende hadden we de mogelijkheid, hetzij in een
relatief kleine populatie, om ook deze nieuwe techniek te vergelijken met de
referentie test DSA. In hoofdstuk 7 worden de resultaten hiervan beschreven.
De diagnostische waarde van CE-MRA was in deze sub-populatie ongeveer gelijk
aan die van TOF MRA, echter, de populatie was te klein om hierover een
nauwkeurige uitspraak te kunnen doen. Daarnaast lijkt CE-MRA een aantal
praktische voordelen te bieden boven TOF MRA. Het optreden van flow void
artefacten lijkt sterk te verminderen, en met deze nieuwe techniek blijkt het
mogelijk om, net als bij DSA, een veel langer traject van de carotis te visualiseren,
van de oorsprong bij de aortaboog tot en met de intra-craniële siphon. Er is niet
bewezen of  een aangetoonde afwijking elders in het traject de resultaten van
chirurgie aan de arteria carotis beïnvloedt, echter, in individuele gevallen weegt
een dergelijke bevinding zeker in de overweging mee.
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In Hoofdstuk 8, tenslotte, onderzochten we wat de patiënten, los van de genoemde
risico’s, zelf vinden van en ervaren bij de drie testen, DUS, MRA en DSA. Zoals we
verwacht hadden werd DSA als meest belastend ervaren, gevolgd door MRA.
Van DUS onderzoek werd weinig hinder ondervonden. Hierbij dient wel te worden
vermeld dat de resultaten mogelijk beïnvloed zijn door het feit dat patiënten met
claustrofobie, of patiënten met metalen implantaten zoals bepaalde vaatclips, niet
deelnamen aan het MRA onderzoek. Bij DSA werden zoals verwacht de vervelende
en/of pijnlijke sensaties van het katheter onderzoek als belastend ervaren.
Opvallend was echter dat de opname in het ziekenhuis die voor DSA, in
tegenstelling tot DUS en MRA, noodzakelijk is, niet als erg belastend werd ervaren.
Het lange stilliggen na het DSA onderzoek, nodig om de snee in de liesslagader
goed te laten genezen, werd als meest belastend gerapporteerd. Ook opvallend
was dat 25% van de patiënten een MRA minder belastend vond dan een DSA.
In de algemene discussie in Hoofdstuk 9 wordt een aantal methodologische beper-
kingen besproken van het uitvoeren en analyseren van diagnostisch onderzoek,
zoals de gevolgen van het uitsluitend betrekken van de carotis aan de
symptomatische zijde in de analyses, en het effect van de verificatie bias op de
resultaten van het DUS onderzoek. Vervolgens wordt kort ingegaan op de toekomst,
waarbij door de ontwikkeling van de techniek een toenemende rol van het MR
onderzoek wordt verwacht. Tenslotte wordt besproken dat in de toekomst
waarschijnlijk meer dan nu het geval is in plaats van alleen de stenosegraad ook
andere karakteristieken van de patiënt, zoals leeftijd, geslacht, en bijvoorbeeld de
tijd sinds het optreden van de symptomen, mee gaan bepalen of een patiënt al dan
niet een operatie geadviseerd moet worden.
De conclusie van dit proefschrift is dat DSA niet meer routinematig dient te worden
uitgevoerd bij alle patiënten die verdacht zijn voor het hebben van een carotis
stenose en bij wie een desobstructie operatie wordt overwogen. DUS alleen is niet
voldoende maar dient altijd gevolgd te worden door MRA onderzoek. Met name de
combinatie van DUS en MRA onderzoek is een veilige en kosteneffectieve niet
invasieve strategie, die de DSA kan vervangen in het merendeel van de patiënten.
DSA dient allen nog te worden verricht op speciale indicatie, bijvoorbeeld wanneer
er een duidelijke discrepantie bestaat tussen de bevindingen van DUS en MRA
onderzoek, of wanneer er aanvullende informatie nodig is van andere vaten voor
de beslissing of een operatie de voorkeur verdient.
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Zonder de hulp van anderen had dit proefschrift niet tot stand kunnen komen.
Een aantal van hen wil ik daarom graag met name bedanken.
Allereerst mijn promotoren,
Prof.dr. Y.van der Graaf, beste Yolanda, jouw manier van begeleiden houdt in dat je
een promovendus erg vrij laat en stimuleert in zijn eigen ideeën en manier van
aanpak. Maar bij problemen stuur je prima bij en je komt vaak met verfrissende en
goede oplossingen. Jouw manier van werken heeft voor mij zeer stimulerend
gewerkt. Ik heb bewondering voor de inspirerende manier waarop jij een grote
onderzoeksgroep zo goed laat samenwerken. Daarnaast heb ik je begeleiding en
ons dagelijks contact als heel erg plezierig ervaren, en ik zal het daarom zeker
gaan missen.
Prof.dr. M.G.M. Hunink, beste Myriam, ondanks de afstand ben je vanaf het eerste
moment betrokken geweest bij ons onderzoek. Ik ben je met name erg dankbaar
voor je expertise in-, en vele hulp met de meta-analyse, dat had ik nooit zelf zo
goed kunnen doen. Bij de hoofdstudie en bij de overige artikelen ben je echter ook
erg betrokken geweest. Door jouw inzet heeft de inclusie in Rotterdam zo goed
kunnen verlopen. Ik wil je hartelijk bedanken voor je vele positieve feedback.
Prof.dr. W.P.Th.M. Mali, beste Willem, ik ben er trots op dat u derde promotor bent.
Uw begeleiding in de afgelopen drie jaar heb ik erg plezierig gevonden.
Uw enthousiasme voor de wetenschap werkt aanstekelijk en inspirerend.
De diepgaande discussies over ons onderwerp en over nieuwe onderzoeksvragen
heb ik bijzonder gewaardeerd en ik hoop dat we die in de toekomst zullen blijven
voeren. Daarnaast waardeer ik zeer uw persoonlijke belangstelling en inzet voor
mijn toekomst.
Door een nauwe samenwerking van de verschillende vakgebieden epidemiologie,
radiologie, neurologie en vaatchirurgie heeft de ABC studie zo goed kunnen
verlopen, en is het mogelijk geweest om de resultaten al tijdens de studie in te
voeren in de klinische praktijk.
Prof.dr. L.J. Kappelle, beste Jaap, ik vond het een groot genoegen om met je samen
te kunnen werken. Jouw expertise op het gebied van ischemische hersenziekten is
de kwaliteit van alle stukken die we samen geschreven hebben zeer ten goede
gekomen. Ik bewonder de integriteit waarmee je de onderzoeksresultaten vertaalt
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naar de beste zorg voor de patiënten. Je bijdrage was zeer groot bij het implementeren
van de resultaten in de praktijk. Ik wil je hartelijk bedanken voor je grote interesse
in- en bijdrage aan mijn proefschrift én mijn verdere toekomst.
Prof.dr. B.C. Eikelboom, u bent vanaf het eerste begin bij de ABC studie betrokken
geweest. Voor u geldt mogelijk nog meer dat u groot voorstander was van het
introduceren van de nieuwe niet-invasieve strategieën in de klinische praktijk.
Dankzij u konden de resultaten en daaruit voortvloeiende voorstellen bij de
vaatchirurgen worden geïntroduceerd. Het was stimulerend om met iemand als u,
met zo’n staat van dienst op het gebied van de carotis pathologie, samen te
kunnen werken. Ik vond het zeer plezierig en heb het erg gewaardeerd dat ik te
alle tijde aan mocht kloppen en altijd op uw belangstelling, aanbevelingen en hulp
kon rekenen.
Naast Prof. Kappelle en Prof. Eikelboom wil ik de overige leden van de commissie
Prof. Grobbee en Prof. Krestin hartelijk danken voor hun bereidwilligheid mijn
manuscript te beoordelen.
Prof. D.E. Grobbee, beste Rick, daarnaast ook hartelijk dank voor je interesse en
persoonlijke belangstelling.
Vervolgens wil ik graag de anderen van de ABC studie groep bedanken.
Dr. O.E.H. Elgersma, beste Otto, een betere voorganger had ik niet kunnen hebben.
Mijn werk sluit direct aan bij het jouwe, en je hebt me enorm geholpen met mijn
stukken. Wanneer het wat moeilijker liep raadde je me vaak aan wat
pragmatischer te werk te gaan en kwam vervolgens zelf helpen bij de uitvoering.
Ik hoop dat onze samenwerking op het gebied van de carotis diagnostiek, maar met
name ook de gezelligheid daaromheen, gewoon doorgaat.
Dr. E. Buskens, beste Erik, jij hebt een enorme hoeveelheid geduld nodig gehad
met het bouwen van de kosteneffectiviteit modellen. Het was een essentieel
onderdeel in deze studie, dat zonder iemand zoals jij niet uitgevoerd had kunnen
worden. We hebben vele inspirerende discussies gevoerd over de uitkomsten van
de modellen. Daarnaast heb ik je collegialiteit als erg plezierig ervaren.
Dr. P.C. Buijs, beste Pieter, bedankt voor je grote bijdrage aan het ontwikkelen van
de scan-protocollen en je bijdrage aan de start van deze studie, en voor alle
adviezen waarvoor ik altijd bij je terecht kon. Met jou wil de twee andere
beoordeelaars, Aloys Wüst en Aad van der Lugt, bedanken voor het eindeloze
169
Dankwoord
geduld maar ook voor de gezelligheid bij het beoordelen van alle angio’s en MRA’s.
Romhild Hoogeveen, hartelijk dank voor je grote technische bijdrage aan de
scan-protocollen
Graag wil ik alle deelnemers aan de ABC studie uit de verschillende ziekenhuizen
bedanken voor hun grote bijdrage bij het includeren van de patiënten.
Utrecht: Prof. van der Graaf, Dr. Elgersma en Dr. Buskens (Julius Centrum),
Prof. Mali (radiologie), Prof. Eikelboom en Dr. Blankensteijn (vaatchirurgie) en
Prof. Kappelle (neurologie). Rotterdam: Prof. Hunink (epidemiologie), Prof. van Urk
(vaatchirurgie), Dr. Dippel (neurologie), Dr. Pieterman (radiologie). Enschede:
De heren van Det en Brouwer (vaatchirurgie), Dr. Huisman (radiologie), en de heer
Leijzer (neurologie).
Bernadette Boerkamp, Thekla Westra, Vera Zuegers, Wibeke van Leeuwen en
Caroline van Bavel, de ABC studie was niet mogelijk geweest zonder jullie grote
inzet in de verschillende ziekenhuizen bij het includeren van alle patiënten en
soepel laten verlopen van alle afspraken en onderzoeken. Michael Edlinger en
Cees Haaring jullie waren onmisbaar voor het data-managment. Tineke en Anneke
van het trailburo, niets was jullie ooit teveel gevraagd. Clarine en Marjan, jullie
regelde altijd alles perfect. Greet, Niels, Marco en alle andere MR laboranten wil
ik bedanken voor het scannen van alle patiënten en het implementeren van  nieuwe
scanprotocollen. Van de afdeling beeldwetenschappen wil ik Cynthia Jongen, Wiro
Niessen, Josien Pluim, Wilbert Bartels en Jeroen van der Grond bedanken voor de
goede samenwerking in de verschillende projecten. Peter Boerlage en Gerard
Horstink, bedankt voor de gezelligheid en plezierige samenwerking.
Christine Broeders, heel erg bedankt voor alle hulp gedurende drie jaar, maar vooral
in de laatste fase, waarbij je me met het kritisch lezen van het manuscript enorm
hebt geholpen.
Dr. A. Algra, beste Ale, je hebt op afstand altijd interesse voor mijn project
getoond. Je collegialiteit heb ik erg gewaardeerd en het Stroke congres Miami was
zeer gezellig.
Roy Sanders, hartelijk dank voor het verzorgen van de lay-out van dit proefschrift
en voor de plezierige wijze waarop we hieraan hebben samengewerkt. Jan, Eugène
en Karin van de fotografie dank ik voor de professionele hulp bij de illustraties voor
artikelen en de presentaties voor congressen.
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Mijn beide paranimfen wil ik hartelijk bedanken voor hun geleverde inspanningen.
Daisy Bloemenkamp, kamergenote, beste Daisy, zoals jij al zei liepen onze
carrières in het Julius Centrum nagenoeg gelijk. Ik wil je bedanken  voor alle
gezelligheid. Je openheid, spontaniteit en interesse in anderen zijn bijzonder. Ik
vond het motiverend om op het eind samen op te kunnen werken naar de
promoties, en je kan trots zijn op jouw prachtige proefschrift.
Chistiaan Kroese, jaargenoot, beste Chris, het lijkt wel, dat naarmate verder je weg
gaat wonen, ons contact nog beter wordt. Ondanks dat we maar kort collega’s
waren in Utrecht, zorgen we er gewoon toch voor dat  we vaak afspreken voor een
biertje na het werk. Het lijkt me zeer gezellig om samen ‘de cursus’ te gaan doen.
Mijn collega arts onderzoekers, Maurice, Maarten, Willemijn, Liesbeth, Marieke,
Jeroen, Bob, Helen, Kristel, Majon, Daniël, Jeroen, Karen en Majanka (azr),  en alle
anderen die ik hier niet bij naam noem op het Julius Centrum en van Epirad,
bedankt voor alle feedback, gezelligheid en de goede sfeer.
Tot slot wil ik graag mijn familie en vrienden bedanken.
De vrienden van mijn studiejaar geneeskunde Koen, Arjen, Martijn, Mark, Jeroen
en de andere vrienden in ons hockeyteam, Chris is jullie vertegenwoordiger van
deze hechte vriendenclub. Martijn, Yvonne, Addy, Nancy, Peter en Elly, op jullie
vriendschap kan ik altijd rekenenen. Peter en Henny, hartelijk dank voor jullie
belangstelling die er altijd is. Onno, Mark, Suzan, Kristel en Arjen, ik hoop dat we
geregeld een avondje zullen afspreken. Maarten, we houden onze traditie met af
en toe een etentje en biertje. Walter, ik kom graag nog een keer langs.
Nicolette, volgens mij hebben wij het al heel gezellig samen.
Marc, Anke, Hans, Elsemieke en Nicolai, op jullie belangstelling en steun heb ik
altijd kunnen rekenen.
Mijn ouders, Nelleke en Pim, heel erg bedankt voor de mogelijkheden die jullie me
altijd hebben geboden, en voor de ondersteuning en liefde waarop ik altijd kon en
kan rekenen.
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